1

David R. Rosenberg, M.D.

Chair, Department of Psychiatry & Behavioral Neurosciences, Wayne State University Director, Translational Neuroscience Initiative, Wayne State University

Phone: 313-577-9000 E-mail: drosen@med.wayne.edu Address: Tolan Park Building 5th Floor Suite 3901 Chrysler Avenue Detroit, Michigan 48201 Date of Birth: January 17, 1963 Place of Birth: New York, New York, U.S.A. Citizenship: U.S.A. Education 1984 B.S. University of Michigan Ann Arbor, Michigan 1988 M.D. University of Michigan Ann Arbor, Michigan Postdoctoral Training Internship: University of Pittsburgh Medical Center, 1988-1989 Pittsburgh, Pennsylvania Residency and Fellowship: Integrated General Psychiatry Residency and 1989-1993 Child Psychiatry Fellowship University of Pittsburgh Medical Center Research Fellowship: National Institute of Mental Health T32 1992-1994 University of Pittsburgh Medical Center Licensure and Certification 1990 Diplomat, National Board of Medicine, 1990 1990-1997 Pennsylvania License, No. 042755 1993 Diplomat, American Board of Psychiatry and Neurology, No. 38413 1994 Diplomat, American Board of Psychiatry and Neurology, Subspecialty Child and Adolescent Psychiatry, No. 3798 1996-Present Michigan License, No. 4301069182

2

Administrative Leadership Positions 1994-1996 Director Obsessive Compulsive Disorders Program Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 1996-2004 Director Child Anxiety Research Division Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan 1996-2004 Director, Obsessive Compulsive Disorders Program, Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan 2004-Present Chief of Child Psychiatry and Psychology, Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan 2006-2008 President Michigan Council of Child and Adolescent Psychiatry Michigan 2011-2012 Interim Chair

Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan

2012-Present Chair Department of Psychiatry, Wayne State University School of Medicine, Detroit, Michigan 2017-Present Chair Department of Neurology Search Committee, Wayne State University School of Medicine, Detroit, Michigan 2017-Present Director Translational Neuroscience Initiative, Wayne State University, Detroit, Michigan Academic Appointments 1994-1996 Assistant Professor of Psychiatry University of Pittsburgh School of Medicine 1996-2000 Associate Professor of Psychiatry Wayne State University School of Medicine 2000-Present Professor of Psychiatry Wayne State University School of Medicine Hospital Appointments 1994-1996 Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania

3

1996-Present Children’s Hospital of Michigan Detroit, Michigan 2004-Present Chief of Child Psychiatry Children’s Hospital of Michigan Detroit, Michigan 2007-2012 Medical Director for Behavioral Health Research and Development, Children’s Hospital of Michigan Detroit, Michigan 2011-Present Psychiatrist in Chief, Detroit Medical Center Detroit, Michigan Other Appointments 1997 High Performance Imaging Committee, Wayne State University School of Medicine 1999-2006 Member, Human Investigation Committee/Institutional Review Board, Wayne State University Detroit, Michigan 2008 Delegate Wayne County Medical Society Southeast Michigan 2008-2011 Executive Committee and Faculty Senate Wayne State University Detroit, Michigan 2016-Present Director Faculty Philanthropy Campaign Wayne State University School of Medicine Detroit, Michigan Awards/Honors/Recognitions 1994 Robinson-Cunningham Award, American Academy of Child and Adolescent Psychiatry for Research Paper 1995 Peter Henderson, M.D. Memorial Award, American Association of Directors of Psychiatric Residency Training 1997 A.E. Bennett Award Paper. Society of Biological Psychiatry 1998 First Prize Winner, Psychopharmacologist Competition International Congress of Neuropsychopharmacology (CINP), Glasgow, Scottland 1999 Dean’s Council Award for Leadership and Teaching

4

1999 Continued Continuing Medical Education, Wayne State University Detroit, Michigan 2000 Keynote Speaker 7th Annual Medical College of Ohio Research Symposium 2000, 2001, 2011 Named Outstanding Mentor, American Academy of Child And Adolescent Psychiatry 2000 Examiner, American Board of Psychiatry and Neurology For Child and Adolescent Psychiatry Board Examination Denver, Colorado 2000 Named Miriam Hamburger Endowed Chair of Child and Adolescent Neuropsychiatric Research 2001 American Academy of Child and Adolescent Psychiatry Norbert Rieger Award for Scientific Achievement 2002 Selected by the American Psychiatric Association and its Committee on Medical Student Education as Recipient Of 12th Annual Nancy C.A. Roeske, M.D. Certificate of Recognition for Excellence in Medical Student Education 2002 Keynote Speaker University of Pittsburgh, Western Psychiatric Institute and Clinic Research Symposium 2002 Invited Lecturer Arvid Carlsson Symposium, Gothenburg, Sweden in honor of the Nobel Laureate Professor, Arvid Carlsson 2002-2011 Dean’s Research Honor Roll for being PI on two or more Federal Grants in single fiscal year. 2004 Psychiatric Times Teacher of the Year Award 2004 New Program of the Year Award (Detroit Wayne Mental Health Agency) in acknowledgement of new program I Directed for provision of innovative services for crisis Intervention for children and adolescents in Detroit And Wayne County 2005 Selected as one of the 20th group of Board of Governors Of Wayne State University Distinguished Faculty Fellows 2005 Reviewer for Thrasher Research Fund 2006 Keynote Speaker, 14th Annual Francis P. Rhoades, M.D. Memorial Lecture, Wayne County Medical Society, Detroit, Michigan 2007 Named to Gerson Lehrman Scholars Program 2008 Named Master Clinician by the Program Committee Of the American Academy of Child and Adolescent Psychiatry

5

2011 Wayne State University’s OCD Clinical Research Program Ranked 9th on a list of the top 10 Treatment Centers 2017 Nominated for Distinguished Fellowship American Psychiatric Association 2017 Nominated by the President of Wayne State University to the National Academy of Medicine (Formerly called Institute of Medicine). 2017 Recognized as Crains Detroit Healthcare Hero 2017 Published research on glutamate recognized as one of top articles published in field of medicine by the London- based journal Faculty 1000 Medicine Governing Board Memberships 2013-Present Wayne State University Physician Group Detroit, Michigan Professional Societies (by invitation) 2000-Present Member, American College of Neuropsychopharmacology (ACNP) 2000-2004 Scientific Advisory Board Anxiety Disorders Association of America (ADAA) 2004-Present Society of Professors of Child and Adolescent Psychiatry 2015-Present American College of Psychiatrists Other Professional Societies 1994-Present American Academy of Child and Adolescent Psychiatry 1996-Present Society of Biological Psychiatry 1996-Present American Psychiatric Association 1998-Present Michigan Obsessive Compulsive Foundation 1998-Present Michigan Tourette Syndrome Foundation 1999-Present Michigan Psychiatric Society 2006-Present Member Wayne County Medical Society 2006-Present Member Michigan State Medical Society 2006-Present Member Michigan Psychiatric Society

6

Editorial Boards 2004-2008 Depression and Anxiety 2007-Present Journal of the American Academy of Child and Adolescent Psychiatry 2007-Present Biological Psychiatry 2008-Present Psychology Research & Behaviour Management Review Activities 1996-Present Reviewer, Peer Review Journals American Journal of Psychiatry Archives of General Psychiatry Behavioural Brain Research Biological Psychiatry Bipolar Disorder Brain Research Depression and Anxiety Journal of Affective Disorders Journal of Autism and Developmental Disorders Journal of Child and Adolescent Psychopharmacology Journal of Child Psychology and Psychiatry Journal of Clinical and Experimental Neuropsychology Journal of Clinical Psychiatry Journal of Psychiatry and Neuroscience Journal of the American Academy of Child and Adolescent Psychiatry Molecular Psychiatry NeuroImage Neuropsychopharmacology Pediatric Radiology Pediatrics Progress in Neuropsychopharmacology and Biological Psychiatry Psychiatry Research: Neuroimaging 2000 National Institute of Mental Health External Grant Reviewer, ZRG1-BBBP-6 05M 2000 National Institute of Mental Health External Grant Reviewer IRG ZMH1 BRB-S(06) 2000 National Institute of Mental Health Reviewer of Grants for Neuroscience and Behavioral Science Review Branch 2001 NIH Reviewer for T32 Institutional Training in Social Sciences and Mental Health CRBJ-01 2001 (February and June) NIH Reviewer BBP-6

7

2002 National Institute of Mental Health Special Emphasis Reviewer for Institutional National Research Service Awards (T32 Applications) 2002 NIH Reviewer for RFA HL 01-006, Sleep and Sleep Disorders in Children 2002 Reviewer for National Institute of Mental Health ZRG1 BBBP-6-02R for Autism START Centers 2003 Biobehavioral and Behavioral Processes (BBBP-6) 2003-2008 Panel reviewer Child Psychopathology and Developmental Disabilities Study Section 2004, 2010 NIH Loan Repayment Program for Assessment Of Applicant’s Potential for a Research Career 2008-Present Ad Hoc Grant Reviewer, National Institute of Mental Health Other Professional Activities 2000 Member of National Institute of Mental Health Workshop Committee: Psychotropic Medications And the Developing Brain: Potential Relevance

Of Animal Models To Child Psychopharmacology

2003-Present Expert Consultant to Laurencelle Foundation Child Psychiatry 2006 Consultant to Department of Psychiatry and Medical School Administration, University of Chicago. Formal Written Report Reviewing Child And Adolescent Psychiatry Section 2006 Committee for Helppie Institute for Child Advocacy in Mental Health Services 2007, 2010, 2011 Representative for Wayne County at the Michigan State Medical Society House of

Delegates 2013 Invited to Address Michigan Governor Synder’s Panel for Mental Health in Michigan 2014 Task Force Convened by James Haveman Director Michigan Department of Community Health for New Approaches to Treat High Frequency Patients with Behavioral Problems in the Emergency Department

8

2015-Present Serving on Lieutenant Governor Calley’s Task Force to Improve Mental Health for Citizens of Michigan National Media Coverage 1997 ABC Good Morning America 1998 CBS News 2002 CNN 2004 PBS 2004 Canadian Broadcasting Company 2009 ABC Prime Time Live 2009 ABC Good Morning America 2009 ABC World News Tonight 2011 ABC Good Morning America 2011 CNN 2011 Oprah Winfrey Network 2012 ABC 20/20 2014 ABC 20/20 2014 ABC Good Morning America 2014 ABC World News Tonight 2015 Interviewed by USA Today 2016 PBS Documentary Death is Not The Answer 2017 Interviewed and Filmed for ABC 20/20 Special to air in Spring/Summer 2017 Other Activities 1996 Expert Consensus Expert Clinical Panel Member for Obsessive Compulsive Disorder Treatment Guidelines Steering Committee

1997 Self Help Group for Children and Families With OCD and How to Use Medicine

9

1998-Present Working with Several Schools, Community Centers to Help Identify Children and Adolescents at High Risk for Attempting and Committing Suicide.

2004 Met with Legislators and Administrators in Lansing to Advocate for Mental Health Initiatives in Detroit and Wayne County 2007 Panel Discussion on “Bipolar Disorder in Children and Adults”, Filmed for Broadcast on Ann Arbor Community Television Network. 2016 Met with and Presented Technology Approaches for Telemedicine/Telepsychiatry to Leadership Federal Communications Commission Grants Grants, Contracts, and other Funding Active National/International Grants and Contracts NIMH R01 MH059299, Brain Function and Genetics in Pediatric Obsessive-Compulsive Behaviors. ”Total Cost $2,200,132. Rosenberg DR, P.I. 2015-2020. This is the most recent Collaborative R01, with the University of Michigan and University of Calgary. Wayne State University is the lead/coordinating center. Dr. Rosenberg is the Lead PI for the 3 sites. Michigan Department of Health and Human Services. Lycaki Young Psychiatry Grant to Wayne State University. Total Cost $5,600,000. Rosenberg DR, P.I. 2017-2018 Children’s Hospital of Michigan Foundation Grant #R1-2017-78 “Innovative Neuroimaging Studies in Childhood Onset Neuropsychiatric Disorders and Children at Increased Risk for Psychiatric Illness $40,000. Rosenberg DR, PI. 1/1/17-12/31/17. Previously funded Grants and Contracts NIMH R01 MH059299, Brain Chemistry and Genetics in Pediatric Obsessive-Compulsive Disorder. Rosenberg DR, PI, 2009-2014. Collaborative R01 grant with the University of Michigan and University of Toronto. DR. Wayne State University was the lead/coordinating center. Dr. Rosenberg was the lead PI for the 3 sites. NIMH 2 K24 MH02037, (Competitive Renewal) Midcareer Investigator Award in Patient-Oriented Research, “Research in Pediatric OCD”. Rosenberg DR, P.I. 2001-2011. NIMH 2 R01 MH59299, (Competitive Renewal), “Brain Chemistry and Treatment Response in Pediatric OCD”, Rosenberg, DR, P.I. 1999-2009. NIMH R01, Assessing Developmental Trajectories of the Brain Biochemistry in ADHD at 4T, Total Cost $2,705,397. Rosenberg DR, Co-Investigator. Stanley J, PI.. 01/15/10 - 12/31/15. Children’s Hospital of Michigan Foundation grant #R1-2014-01-02 “Imaging Study of Bipolar Disorder $240,379, 01/1/14 - 12/31/15.

10

NIMH 1 R01 MH70949 “Substance Use Outcomes Following Treatment for Adolescent Depression (SOFTAD)”. Total Cost $190,000, Rosenberg, DR. Wayne State site PI on this Collaborative R01. 9/1/03-3/1/09. NIMH (RFP-NIH-NIMH), Human Genetics Initiative – TADS add-on, Treatment for Adolescent Depression Study (TADS). Rosenberg, DR, P.I., WSU. Total Cost $40,000.00, 1/03 – 1/04. Mental Illness Research Association, “Brain Chemistry in Treatment Refractory Pediatric OCD”, Rosenberg DR, P.I., Total Cost $29,951. September 1, 2003 – August 31, 2004. National Alliance for Research in Schizophrenia and Affective Disorders (NARSAD) Established Investigator Award, "Proton MRS in Pediatric Major Depressive Disorder: Monitoring of Fluoxetine-induced Modulation of Brain Choline", Rosenberg DR, P.I., Total Cost $100,000, September 15, 2000-March 14, 2003. NIMH R01 MH65122 "Brain chemistry and treatment response in pediatric MDD". Rosenberg DR, P.I., Total Cost $1,527,250. 2001-2006. NIMH 2 R01 MH59299, “Brain chemistry and treatment response in pediatric OCD”. Rosenberg DR, P.I., Total Cost $2,672,817. 1999-2009. NIMH (RFP-NIH-NIMH 98-DS-0008) TADS Trial (Treatment of Adolescent Depression Study), Rosenberg D.R., P.I., Total Cost $500,000, 1999-2006. Stanley Foundation, “Monitoring of Lithium Induced Changes in Brain Myo-Inositol in Adolescents with Bipolar Disorder”, P.I., Gregory Moore, Ph.D., Rosenberg DR and Manji H, co-investigators, Total Cost, $150,000, 9/1/98-8/31/01. National Obsessive Compulsive Foundation, “Psychobiology and Treatment of SSRI-Resistant Obsessive Compulsive Disorder”, Rosenberg D.R., P.I., Total Cost $25, 804. January 1, 1997 to December 31, 1998. NIMH MH-K0801372, “Fronto-Striatal Pathology of Childhood OCD”, Rosenberg DR, P.I., Total Cost $718,014. May 1, 1996-April 30, 2001, PUBLICATIONS Peer-Reviewed Publications Reports of Original Work Rosenberg DR, Neylan TC, El-war M, Peters JL, van Kammen DP: Neuropsychiatric symptoms associated with idiopathic calcification of the basal ganglia. Journal of Nervous and Mental Disease 1991; 170(1): 48-49. Rosenberg DR, Pajer K, Rancurello M: Initial neuropsychiatric assessment of one Romanian orphanage for “unsalvageables”. JAMA 1992; 268(24): 3489-3490. Rosenberg DR, Lewis DA: Changes in the dopaminergic innervation of monkey prefrontal cortex during late postnatal development: A tyrosine hydroxylase immunohistochemical study. Biological Psychiatry 1994; 36: 272-277. Rosenberg DR, Lewis DA: Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: A tyrosine hydroxylase immunohistochemical analysis. Journal of Comparative Neurology 1995; 358: 383-400.

11

Sweeney JA, Mintun MA, Kwee S, Wiseman MB, Brown DL, Rosenberg DR, Carl JR: Positron emission tomography study of voluntary saccadic eye movements and spatial working memory. Journal of Neurophysiology 1996; 75: 454-468. Rosenberg DR, Averbach DH, O’Hearn KM, Seymour AB, Birmaher B, Sweeney JA: Oculomotor response inhibition abnormalities in pediatric obsessive compulsive disorder. Archives of General Psychiatry 1997; 54(9): 831-838. Rosenberg DR, Keshavan MS, O’Hearn KM, Dick EL, Bagwell WW, Seymour AB, Montrose DM, Pierri JN, Birmaher B: Frontostriatal measurement in treatment-naive pediatric obsessive compulsive disorder. Archives of General Psychiatry 1997; 54(9): 824-830. Rosenberg DR, Dick EL, O’Hearn KM, Sweeney JA: Response inhibition deficits in obsessive compulsive disorder: an indicator of dysfunction in fronto-striatal circuits. Journal of Psychiatry and Neuroscience 1997; 22: 29-38. Rosenberg DR, Sweeney JA, Squires-Wheeler E, Keshavan MS, Cornblatt BA, Erlenmeyer-Kimling L: Eye tracking dysfunction in offspring from the New York high risk project: Diagnostic specificity and the role of attention. Psychiatry Research 1997; 66: 121-130. Rosenberg DR, Sweeney JA, Gillen JS, Kim J, Varanelli MJ, O’Hearn KM, Erb PA, Davis D, Thulborn KR: Magnetic resonance imaging of children without sedation: preparation with simulation. Journal of the American Academy of Child and Adolescent Psychiatry 1997; 36: 853-859. Rosenberg DR, Keshavan MS, Dick EL, Bagwell WW, MacMaster F, Seymour AB, Birmaher B: Corpus callosal morphology in treatment-naive pediatric obsessive compulsive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1997; 21: 1269-1283. Rosenberg DR, Gershon S: Developmental constructs in neuropsychiatric research. Developmental Brain Dysfunction 1997; 10:96-117. Keshavan MS, Montrose DM, Pierri JN, Dick EL, Rosenberg DR, Talagala L, Sweeney JA: Magnetic resonance imaging and spectroscopy in offspring at risk for schizophrenia: Preliminary studies. Progress in Neuropsychopharmacology and Biological Psychiatry 1997; 21: 1285-1295. Rosenberg DR, Keshavan MS: A.E. Bennett Award Paper - Toward a neurodevelopmental model of obsessive compulsive disorder. Biological Psychiatry 1998; 43(9): 623-640. Keshavan MS, Rosenberg DR, Sweeney JA, Pettegrew JW: Decreased caudate volume in neuroleptic-naive psychotic patients. American Journal of Psychiatry 1998; 155: 774-778. Beers SR, Rosenberg DR, Dick EL, Williams T, O’Hearn KM, Birmaher B, Ryan CM: Neuropsychological studies of frontal lobe function in psychotropic-naive pediatric obsessive compulsive disorder. American Journal of Psychiatry 1999; 156: 777-779. Rauch SL, Benkelfat C, Dager SR, Greenberg BD, Hendler T, Hollander E, Laruelee M, Rosenberg DR, Saxena S, Zohar J, Baxter LR: Neuroimaging research and neurocircuitry models of obsessive-compulsive disorder: Proceedings of the third IOCDC; CNS Spectrums 1999; 4:5 (suppl 3): 25-34. MacMaster F, Dick EL, Keshavan MS, Rosenberg DR: Corpus callosal signal intensity in treatment-naive pediatric obsessive compulsive disorder. Progress in Neuropsychopharmacology and Biological Psychiatry 1999; 23(4): 601-612. Keshavan MS, Rosenberg DR: New trends in developmental neuroimaging in psychiatry. Progress in Neuropsychopharmacology and Biological Psychiatry 1999; 23(4): 557-560.

12

Rosenberg DR, Stewart C, Fitzgerald K, Tawiles V, Carroll E: Paroxetine open-label treatment of pediatric outpatients with obsessive compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1999; 38(9): 1180-1185. Fitzgerald KD, Moore GJ, Paulson LD, Stewart CM, Rosenberg DR: Priority Communication: Proton spectroscopic imaging of the thalamus in treatment naïve pediatric obsessive compulsive disorder. Biological Psychiatry 2000; 47(3): 174-182. Gilbert AR, Moore GJ, MacMaster FP, Paulson LD, Keshavan MS, MacDonald AD, Stewart CM, Rosenberg DR: Decrease in thalamic volume in pediatric obsessive compulsive disorder patients taking paroxetine. Archives of General Psychiatry. 2000; 57(5): 449–456. Rosenberg DR, MacMaster FP, Keshavan MS, Fitzgerald KD, Stewart C, Moore GJ: Rieger Award - Decrease in caudate glutamatergic concentrations in pediatric obsessive compulsive disorders patients taking paroxetine. Journal of the American Academy of Child and Adolescent Psychiatry. 2000; 39(9): 1096-1103. Beers SR, Rosenberg DR, Ryan CM: Cognitive deficits in obsessive compulsive disorder. American Journal of Psychiatry [letter] 2000; 157: 1182-1183. Rosenberg DR, Benazon N, Gilbert A, Sullivan A, Moore GJ: Thalamic volume in pediatric obsessive compulsive disorder patients before and after cognitive behavioral therapy. Biological Psychiatry 2000; 48 (4): 294-300. Rosenberg DR, Hanna GH: Genetic and imaging strategies in obsessive-compulsive disorder: Potential implications for treatment development. Biological Psychiatry 2000; 48(12): 1210-1222. Gilbert AR, Rosenberg DR, Harenski K, Spencer S, Sweeney JA, Keshavan MS: Thalamic volumes in patients with first episode schizophrenia. American Journal of Psychiatry 2001; 158: 618-624. Rosenberg DR, MacMillan S, Moore GJ: Brain anatomy and chemistry may predict treatment response in pediatric obsessive compulsive disorder. International Journal of Neuropsychopharmacology 2001; 4(2): 179 - 190. Rosenberg DR, Amponsah A, Sullivan A, MacMillan S, Moore GJ: Increased medial thalamic choline in pediatric obsessive compulsive disorder as detected by quantitative in vivo spectroscopic imaging. Journal of Child Neurology 2001; 16(9): 636-641. Nolan CL, Moore GJ, Madden R, Farchione T, Bartoi M, Lorch E, Stewart CM, Rosenberg DR: Prefrontal cortical volume in childhood-onset major depression: Preliminary findings. Archives of General Psychiatry 2002; 59: 173-179. Benazon NR, Ager J, Rosenberg DR: Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: An open trial. Behaviour Research and Therapy 2002; 40: 529-539. Keshavan MS, Diwadkar VA, Bagwell WW, Harenski K, Rosenberg DR, Sweeney JA, Pettegrew JW: Abnormalities of the corpus callosum in first-episode treatment-naive schizophrenia. Journal of Neurology, Neurosurgery, and Psychiatry 2002; 72(6): 757-760. Keshavan MS, Diwadkar VA, Dick E, Kotwal R, Rosenberg DR, Sweeney JA, Minshew, N, Pettegrew JW: Development of the corpus callosum in childhood adolescence and early adulthood. Life Sciences 2002; 70(16): 1909-1922.

13

Farchione TR, Moore GJ, Rosenberg DR: Proton magnetic resonance spectroscopic imaging in pediatric major depression. Biological Psychiatry 2002; 52(2) 86-92. MacMillan SN, Szeszko PR, Moore GJ, Madden R, Lorch E, Ivey J, Banerjee, SP, Rosenberg DR: Increased amygdala:hippocampal volumes associated with severity of anxiety in pediatric major depression. Journal of Child and Adolescent Psychopharmacology 2003; 13(1): 63-71. Posse S, Fitzgerald D, Gao K, Habel U, Rosenberg D, Moore G, Schneider F: Real-time fMRI of temporo-limbic regions detects amygdala activation during single trial self-induced sadness. Neuroimage 2003; 18(3): 760-768. Treatment for Adolescents with Depression Study (TADS) Team: Treatment for Adolescents with Depression Study (TADS): Rationale, design and methods. Journal of the American Academy of Child and Adolescent Psychiatry 2003; 42(5): 531-542. Russell A, Cortese B, Lorch E, Ivey J, Banerjee SP, Moore GJ, Rosenberg DR: Localized functional neurochemical marker alterations in dorsolateral prefrontal cortex in pediatric obsessive compulsive disorder. Journal of Child and Adolescent Psychopharmacology 2003; 13 (suppl 1): 31-38. Benazon NR, Moore GJ, Rosenberg DR: Neurochemical analyses in pediatric obsessive-compulsive disorder patients treated with cognitive behavioral therapy. Journal of the American Academy of Child and Adolescent Psychiatry 2003; 42(11): 1279-1285. Smith E, Russell A, Lorch E, Banerjee SP, Rose M, Ivey J, Bhandari R, Moore GJ, Rosenberg DR: Increased medial thalamic choline found in pediatric patients with obsessive compulsive disorder vs. major depression or healthy controls: An MRS study. Biological Psychiatry 2003; 54(12): 1399-1405. Mirza Y, Tang J, Russell A, Banerjee SP, Bhandari R, Ivey J, Rose M, Moore GJ, Rosenberg DRR: Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. Journal of the American Academy of Child and Adolescent Psychiatry 2004; 43(3): 341-348. Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Head D, Lim KO, Ivey J, Rose M, Banerjee SP, Bhandari R, Moore GJ, Rosenberg DR: Brain structural abnormalities in psychotropic drug-naive pediatric obsessive compulsive disorder. American Journal of Psychiatry 2004; 161(6): 1049-1056. Szeszko PR, MacMillan S, McMeniman M, Lorch E, Madden R, Ivey J, Banerjee SP, Moore GJ, Rosenberg DR: Decrease in amygdala volume in pediatric patients with obsessive compulsive disorder treated with paroxetine. Neuropsychopharmacology 2004; 29: 826-832. Rajarethinam R, Sahni S, Rosenberg DR, Keshavan MS: Reduced superior temporal gyrus volume in young offspring of patients with schizophrenia. American Journal of Psychiatry 2004; 161(6): 1121-1124. Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA: Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: A preliminary study. Psychopharmacology 2004; 174(4): 530-538. The Treatment for Adolescents with Depression Study (TADS) Team: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents with Depression Study (TADS) randomized controlled trial. JAMA 2004; 292(7): 807-820. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee P, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ: Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression vs. healthy controls. Journal of the American Academy of Child and Adolescent Psychiatry 2004; 43(9): 1146-1153.

14

The Treatment for Adolescents with Depression Study (TADS) Team. The Treatment for Adolescents with Depression Study (TADS): Demographic and clinical characteristics. Journal of the American Academy of Child and Adolescent Psychiatry 2005; 44(1): 28-40. Banerjee S, Bhandari R, Rosenberg D: Use of low-dose selective serotonin reuptake inhibitors for severe, refractory choking phobia in childhood. Journal of Developmental and Behavioral Pediatrics 2005; 26(2): 1-5. Rosenberg DR, MacMaster F, Mirza Y, Smith JM, Easter P, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Villafuerte RA, Moore GJ, Renshaw P. Reduced anterior cingulate glutamate in pediatric major depression: A magnetic resonance spectroscopy study. Biological Psychiatry 2005; 58(9): 700-704. Keshavan M, Diwadkar V, Rosenberg DR: Developmental biomarkers in schizophrenia and other psychiatric disorders: Common origins, different trajectories? Epidemiologia e Psichiatria Sociale, 2005; 14(4): 188-193. Kratochvil CJ, Simons A, Vitiello B, Walkup J, Graham E, Rosenberg D, March J: A multisite psychotherapy and medication trial for depressed adolescents: Background and benefits. Cognitive and Behavioral Practice 2005; 45(12): 159-165. Mirza Y, O’Neill J, Smith EA, Russell A, Smith JM, Banerjee SP, Bhandari R, Boyd C, Rose M, Ivey J, Renshaw PF, Rosenberg DR: Increased medial thalamic creatine/phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. Journal of Child Neurology 2006; 21(2) 106-111. MacMaster FP, Russell A, Mirza Y, Keshavan M, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR: Pituitary volume in pediatric obsessive compulsive disorder. Biological Psychiatry 2006; 59:252-257. MacMaster FP, Russell A, Mirza Y, Keshavan MS, Taormina SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR. Pituitary volume in treatment-naive pediatric major depressive disorder. Biological Psychiatry 2006; 60(8): 862-866. Rosenberg DR, MacMaster FP, Mirza Y, Easter PC: Imaging and neurocircuitry of pediatric major depression. Clinical Neuropsychiatry 2006; 3: 219-229. March JS, Silva SG, Vitiello B and the TADS Team. The Treatment for Adolescents with Depression Study (TADS): Methods and message at twelve weeks. Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45(12): 1393-1403. Curry J, Rhode P, Simons A, Silva S, Vitiello B, Kratochvil C, Reinecke M, Feeny N, Wells K, Pathak S, Weller E, Rosenberg D, Kennard B, Robbins M, Ginsberg G, March J, and the TADS Team: Predictors and moderators of acute treatment outcome in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45 (12) 1427-1439. Vitiello B, Rhode P, Silva S, Wells K, Casat C, Waslick B, Simons A, Reinecke M, Weller E, Kratochvil C, Walkup J, Pathak S, Robbins M, March J and the TADS Team. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS) Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45(12): 1419-1426. Emslie G, Kratochvil C, Vitiello B, Silva S, Mayes T, McNulty S, Weller E, Waslick B, Casat C, Walkup J, Pathak S, Rohde P, Posner K, March J and the TADS Team. Treatment for Adolescents with Depression Study: Safety results. Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45(12): 1440-1455.

15

Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, Hughes J, Feeny N, Weller E, Sweeney M, Reinecke M, Pathak S, Ginsburg G, Emslie G, March and the TADS Team: Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45(12): 1404-1411. Kratochvil C, Emslie G, Silva S, McNulty S, Walkup J, Curry J, Reinecke M, Vitiello B, Rohde P, Feeny N, Casat C, Pathak S, Weller E, May D, Mayes T, Robins M, March J; and the TADS Team: Acute time to response in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry 2006; 45(12): 1412-1418. MacMaster FP, Keshavan MS, Mirza Y, Carrey N, Upadhyaya AR, El-Sheikh R, Buhagiar CJ, Taormina SP, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR. Development and sexual dimorphism of the pituitary gland. Life Sciences 2007; 80(10): 940-944. Mahajan P, Thomas R, Rosenberg DR, Leleszi JP, Mathur A, Knazik SR: Evaluation of a child-guidance model for visits for mental disorders to an inner city pediatric emergency department. Pediatrics Emergency Care 2007; 23 (4): 212-217. The Treatment for Adolescents with Depression Study (TADS) Team: The Treatment for Adolescents with Depression Study (TADS): Long-term effectiveness and safety outcomes. Archives of General Psychiatry 2007; 64(10): 1132-1144. MacMaster FP, El-Sheikh R, Upadhyaya AR, Nuche J, Rosenberg DR, Keshavan M: Effect of antipsychotics on pituitary gland volume in treatment-naive first episode psychosis: a pilot study. Schizophrenia Research 2007; 92(1-3):207-10. Gilbert AR, Keshavan MS, Diwadkar V, Nutche J, MacMaster FP, Easter PC, Buhagiar CJ, Rosenberg DR: Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: A preliminary voxel-based morphometry study. Neuroscience Letters 2008; 435(1):45-50. Matsuo K, Rosenberg DR, Easter PC, MacMaster FP, Hua-Hsuan C, Nicolleti M, Caetano SC, Hatch JP, Soares JC: Striatal volume abnormalities in treatment-naive pediatric major depressive disorder patients. Journal of Child and Adolescent Psychopharmacology 2008; 18(2): 121-131. MacMaster FP, Leslie R, Rosenberg DR, Kusumakar V: Pituitary gland volume in adolescent bipolar and unipolar depression. Bipolar Disorders 2008; 10(1): 101-104. MacMaster FP, Mirza Y, Szeszko P, Kmiecik LE, Easter PC, Taormina P, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR: Amygdala-hippocampal volumes in familial pediatric major depressive disorder. Biological Psychiatry, 2008; 63(4): 385-90. Szeszko PR, Christian C, MacMaster F, Lencz T, Mirza Y, Easter PC, Taormina P, Rose M, Michalopoulou G, Rosenberg DR: Gray matter structural alterations in psychotropic drug- naïve children pediatric obsessive compulsive disorder: An optimized voxel based morphometry study. American Journal of Psychiatry. 2008 165: 1299-1307. Chen HH, Rosenberg DR, MacMaster FP, Easter PC, Caetano SC, Nicoletti M, Hatch JP, Nery FG, Soares JC: Orbitofrontal cortex volumes in medication naïve children with major depressive disorder: A magnetic resonance imaging study. Journal of Child and Adolescent Psychopharmacology 2008; 18:551-556. MacMaster F, O’Neil J, Rosenberg D: Brain imaging in pediatric obsessive compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2008; 47:11 1263-1273.

16

MacMaster FP, Moore GJ, Russell A, Mirza Y, Taormina SP, Buhagiar CJ, Rosenberg DR: Medial temporal N-acetyl aspartate in pediatric major depression. Psychiatry Research: Neuroimaging 2008; 164(1):86-89. Feeny NC, Silva SG, Reinecke M, McNulty S, Findling RL, Rohde P, Curry J, Ginsberg G, Kratochvil CJ, Pathak S, May D, Kennard E, Simons A, Wells K, Robins M, Rosenberg DR, March J: An exploratory analysis of the impact of family functioning on treatment for depression adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2009; 38(6): 814-825. Arnold PD, Richter MA, Hanna GL, Sicard T, Burroughs E, MacMaster FP, Mirza Y, Easter PC, Rose M, Kennedy JL, Rosenberg DR: Glutamate system genes associated with ventral prefrontal and thalamic volume in pediatric obsessive-compulsive disorder. Brain Imaging and Behavior 2009; 3(1) 64-67. Arnold PD, MacMaster FP, Richter MA, Hanna GL, Sicard T, Burroughs E, Mirza Y, Easter PC, Rose M, Kennedy JL, Rosenberg DR: Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive–compulsive disorder. Psychiatry Research: Neuroimaging 2009; 172(2): 136–139. Michalopoulou G, Falzarano P, Arfken C, Rosenberg D: Physicians’ cultural competency and associated factors as perceived by African American patients. Journal of the National Medical Association 2009; 101: 893-899. Michalopoulou G, Falzarano P, Rosenberg DR: Recruitment of African Americans for obsessive compulsive disorder treatment research. Journal of Health Disparities Research and Practice 2009: 3(1): 71-82. Rogers GM, Park J, Essex MJ, Klein MH, Silva SG, Hoyle RH, Curry JF, Feeny NC, Kennard B, Kratochvil CJ, Pathak S, Reinecke MA, Rosenberg DR, Weller EB, March, JS: The dysfunctional attitudes scale: Psychometric properties in depressed adolescents. Journal of Clinical Child and Adolescent Psychology 2009; 38(6): 781-789. MacMaster F, Anvi V. Easter P, Rix C, Rosenberg DR: Orbital frontal cortex in pediatric obsessive-compulsive disorder. Psychiatry Research: Neuroimaging 2010; 181: 97-100. Arnold PD, Hanna GL, Rosenberg DR: Imaging the amygdala: changing the face of gene discovery in child psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry 2010 49(1):7-10. Michalopoulou G, Falzarano P, Arfken C, Rosenberg D: Implementing Ask Me 3 to improve African American patient satisfaction and perceptions of physician cultural competency. Journal of Cultural Diversity 2010; 17(2), 62-67. Michalopoulou G, Falzarano P, Hakim-Larson J, Wittmann D, Maldaver M, Chambers J, Vanbrussel A, Rosenberg D: A multi-disciplinary approach to early childhood mental health intervention. Early Childhood Services: An Interdisciplinary Journal of Effectiveness 2010; 4(4): 199-211. MacMaster FP, Rosenberg DR: Neurobiological evidence supporting glutamate’s role in pediatric obsessive compulsive disorder. Child & Adolescent Psychopharmacology News 2010;15(6): 6-10,12. MacMaster FP, Rosenberg DR: The use of glutamate modulating drugs in obsessive compulsive disorder. Child & Adolescent Psychopharmacology News 2010; 15(6):1-5. Fallucca E, MacMaster FP, Haddad J, Easter P, Dick R, May G, Stanley JA, Rix C, Rosenberg DR: Distinguishing between major depressive disorder and obsessive-compulsive disorder in children by measuring regional cortical thickness. Archives of General Psychiatry 2011; 68(5):527-533.

17

Wu K, Hanna, G, Kennedy J, Rosenberg DR, Arnold P: The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder; Corresponding Author: Dr. Paul Daniel Arnold. Pharmacology, Biochemistry and Behavior 2012; 100(4): 726-735. Angoa-Peréz M, Kane MJ, Briggs DI, Sykes CE, Shah MM, Francescutti DM, Rosenberg DR, Thomas DM, Kuhn DM: Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. Journal of Neurochemistry 2012; 121: 974-984. Kane MJ, Angoa-Peréz M, Briggs DI, Sykes CE, Francescutti DM, Rosenberg DR, Kuhn DM: Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: Possible relevance to autism. PLOS One: 2012; 7(11) e48975. Stewart SE, Dongmei Yu D, Scharf JM, Neale MB, Fagerness JA, Mathews CA, Arnold PD, Evans PD, Gamazon ER, Osiecki L, Haddad S, Crane J, Hezel D, Mayerfeld C, Konkashbaev A, Liu C, Pluzhnikov A, Tikhomirov A, Rauch SL, Moessner R, Falkai P, Maier W, Ruhrmann S, Grabe HJ, Lennertz L, Wagner M, Bellodi L, Cavallini MC, Richter MP, Cook EH, Kennedy JL, Rosenberg D, Stein DJ, Lochner C, Azzam A, Chavira DA, Fournier E, Garrido H, Sheppard B, Umaña P, Murphy DL, Wendland JR, Veenstra-Vander Weele JM, Denys D, Blom R, Deforce D, Walitza S, Egberts K, Renner T, Miguel EC, Cappi C, Hounie AG, Conceição do Rosário M, Sampaio AS, Vallada H, Nicolini H, Delorme R, Leboyer M, Pato CN, Pato MT, Heutink P, Cath DC, Smit JH, Samuels J, Bienvenu OJ, Cullen B, Fyer AJ, Grados MA, Greenberg BD, McCracken JT, Riddle MA, Wang Y, Leckman JF, Bloch M, Pittinger C, Eapen V, Black DW, Ophoff RA, Strengman E, Cusi D, Turiel M, Frau F, Macciardi F, Gibbs JR, Singleton A, Hardy J, Crenshaw AT, Parkin MA, Mirel DB, Purcell S, Nestadt G, Hanna GL, Jenike MA, Knowles JA, Cox N, Pauls DL: Genome-wide association study of obsessive-compulsive disorder. Molecular Psychiatry 2013; 18(7): 788-798. Wu K, Hanna GL, Easter P, Kennedy JL, Rosenberg DR, Arnold P: Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: A Preliminary Study. Psychiatry Research: Neuroimaging. 2013; 211(3):214-20. Davis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, Neale BM, Yang J, Lee SH, Evans P, Barr CL, Bellodi L, Benarroch F, Berrio GB, Bienvenu OJ, Bloch MH, Blom RM, Bruun RD, Budman CL, Camarena B, Campbell D, Cappi C, Cardona Silgado JC, Cath DC, Cavallini MC, Chavira DA, Chouinard S, Conti DV, Cook EH, Coric V, Cullen BA, Deforce D, Delorme R, Dion Y, Edlund CK, Egberts K, Falkai P, Fernandez TV, Gallagher PJ, Garrido H, Geller D, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Haddad S, Heiman GA, Hemmings SM, Hounie AG, Illmann C, Jankovic J, Jenike MA, Kennedy JL, King RA, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Macciardi F, McCracken JT, McGrath LM, Mesa Restrepo SC, Moessner R, Morgan J, Muller H, Murphy DL, Naarden AL, Ochoa WC, Ophoff RA, Osiecki L, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner TJ, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosàrio MC, Rosenberg D, Rouleau GA, Ruhrmann S, Ruiz-Linares A, Sampaio AS, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Valencia Duarte AV, Vallada H, Van Nieuwerburgh F, Veenstra-Vanderweele J, Walitza S, Wang Y, Wendland JR, Westenberg HG, Shugart YY, Miguel EC, McMahon W, Wagner M, Nicolini H, Posthuma D, Hanna GL, Heutink P, Denys D, Arnold PD, Oostra BA, Nestadt G, Freimer NB, Pauls DL, Wray NR, Stewart SE, Mathews CA, Knowles JA, Cox NJ, Scharf JM.: Partitioning the heritability of Tourette Syndrome and obsessive compulsive disorder reveals differences in genetic architecture. PLOS Genet: 2013: Oct;9(10). Malhi G, Rosenberg DR, Gershon S: Staging a protest. Bipolar Disorder 2014; 16(7): 776-779. Diwadkar VA, Burgess A, Hong E, Rix C, Arnold PD, Hanna GL, Rosenberg DR: Dysfunctional activation and brain network profiles in youth with Obsessive-Compulsive Disorder: A focus on the dorsal anterior cingulate during working memory. Frontiers in Human Neuroscience, 2015; 9: 1-11.

18

Friedman AL, Burgess A, Ramaseshan K, Easter P, Khatib D, Chowdury A, Arnold PD, Hanna GL, Rosenberg DR, Diwadkar VA: Brain network dysfunction in youth with obsessive compulsive disorder induced by simple uni-manual behavior: the role of the dorsal anterior cingulate cortex. Psychiatry Research: Neuroimaging. In Press. Case Reports Rosenberg DR: Idiopathic edema (letter). Hospital and Community Psychiatry 1991; 42(10):1072. Rosenberg DR, Crowner S, Thomas C, Gourash L: Psychosis with idiopathic precocious puberty. Child Psychiatry and Human Development 1992; 22: 287-292. Rosenberg DR, Johnson K, Sahl R: Evolving mania in an adolescent treated with low dose fluoxetine. Journal of Child and Adolescent Psychopharmacology 1992; 2: 299-305. Moore G, MacMaster F, Stewart C, Rosenberg DR: Case study: Caudate glutamatergic changes with paroxetine therapy for pediatric obsessive compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1998; 27(6): 663-667. Go F, Malley E, Birmaher B, Rosenberg DR: Fluoxetine-induced mania in pediatric obsessive compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 1998; 8: 73-80. Figueroa Y, Rosenberg DR, Birmaher B, Keshavan MS: Treatment of pediatric obsessive compulsive disorder with clomipramine-SSRI combinations. Journal of Child and Adolescent Psychopharmacology 1998; 8:61-67. Fitzgerald K, Tawiles V, Stewart C, Rosenberg DR: Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder. Journal of Child and Adolescent Psychopharmacology 1999; 9(2):115-123. Bolton J., Moore GJ, MacMillan S, Stewart CM, Rosenberg DR: Caudate glutamatergic changes with paroxetine persist after medication discontinuation in pediatric OCD. Journal of the American Academy of Child and Adolescent Psychiatry 2001; 40(8): 903-906. Farchione TR, Lorch E, Rosenberg DR: Hypoplasia of the corpus callosum and obsessive-compulsive symptoms. Journal of Child Neurology 2002 (17)(6): 535-537. Review Articles Rosenberg DR, Wright BA, Gershon S: Cognitive-enhancing agents for the treatment of senile dementia of the Alzheimer’s type. Drugs of Today 1990; 26(7): 449-471. Nelson JP, Rosenberg DR: ECT treatment of demented elderly patients with major depression: A retrospective study of efficacy and safety. Convulsive Therapy 1991; 7(3): 157-165. Wright BA, Rosenberg DR, Gershon S: Potential treatment modalities for senile dementia of the Alzheimer’s type. Neurology Forum 1990; 1(3): 2-7. Rosenberg DR, Wright BA, Gershon S: Depression in the Elderly. Dementia 1992; 3: 157-173. Ivey, JL, Rosenberg, DR. An overview of clomipramine’s role in the treatment of obsessive compulsive disorder. Expert Review of Neurotherapeutics. 2002 2(6): 783-790. Rosenberg DR, Banerjee S, Ivey J, Lorch E: Psychopharmacology of child and adolescent anxiety disorders. Psychiatric Annals 2003; 33: 273-278.

19

Arnold PD, Banerjee P, Bhandari R, Lorch E, Ivey J, Rose M, Rosenberg DR: Childhood anxiety disorders and developmental issues in anxiety. Current Psychiatry Reports 2003; 5(4): 252-265. MacMaster FP, Rosenberg DR. Glutamate and the treatment of obsessive compulsive disorder. Psychopharmacology Review 2010; 45(5) 33-39. Briles JJ, Rosenberg DR, Brooks BA, Roberts MW, Diwadkar VA: Second generation antipsychotics: Are they really “atypically” safe in the long-run for youth and adults? The Primary Care Companion for CNS Disorders 2012; 14(3). Editorials/Commentaries Krystal JH, Carter CS, Geschwind D, Manji HK, March JS, Nestler EJ, Zubieta JK, Charney DS, Goldman D, Gur, RE, Lieberman JA, Byrne PR, Rubinow DR, Anderson SA, Barondes S, Berman KF, Blair J, X Braff DL, Brown ES, Calabrese JR, Carlezon WA, Cook EH, Davidson RJ, Davis M, Desimone R, Drevets WC, Duman RS, Essock SM, Faraone SV, Freedman R, Friston KJ, Gelernter J, Geller B, Gill M, Gould E, Grace AA, Grillon C, Gueorguieva R, Hariri AR, Innis RB, Jones EG, Kleinman JE, Koob GF, Krystal AD, Leibenluft E, Levinson DF, Levitt PR, Lewis DA, Liberzon I, Lipska BK, Marder SR, Markou A, Mason GF, McDougle CJ, McEwen BS, McMahon FJ, Meaney MJ, Meltzer HY, Merikangas KR, Meyer-Lindenberg A, Mirnics K, Monteggia LM, Neumeister A, O’Brien CP, Owen MJ, Pine DS, Rapoport JL, Rauch SL, Robbins TW, Rosenbaum JF, Rosenberg DR, Ross CA, Rush AJ, Sackeim HA, Sanacora G, Schatzberg AF, Shaham Y, Siever LJ, Sunderland T, Tecott LH, Thase ME, Todd RD, Weissman MM, Yehuda R, Yoshikawa T, Young EA, McCandless R: It is time to take a stand for medical research and against terrorism targeting medical scientists. Biological Psychiatry 2008 April 63:725-727. Harper J: Scientists rip animal protection activists. Washington Times April 10, 2008. MacMaster FP, Rosenberg DR: Commentary on: Magnetic Resonance Imaging (MRI) – Reviewing the process of preparing children for MRI. Pediatric Radiology 2008; 38:270. Arnold P, Hanna G, Rosenberg DR: Invited Editorial, Imaging the amygdala: changing the face of gene discovery in child psychiatry. Journal of the American Academy of Child and Adolescent Psychiatry 2010; 49(1): 7-10. Letters to the Editor Book Authorship, Editorships, and Chapters Wright BA, Rosenberg DR, Gershon S: New strategies for the pharmacologic therapy of adult onset cognitive disorders. In: Crook T and Gershon S, eds. Diagnosis and Treatment of Adult Onset Cognitive Disorders. Psymark Communications (1991). Rosenberg DR, Holttum J, Gershon S: Textbook of Pharmacotherapy for Childhood and Adolescent Psychiatric Disorders. Bruner/Mazel: New York (1994). Tanner TB, Rosenberg DR: The Psychiatric Interview: A Focused Approach. Health Guide Publications: Pittsburgh (1996). Rosenberg DR, Holttum J, Ryan N, Gershon S: Pocket Guide for Drug Therapy of Childhood and Adolescent Psychiatric Disorders. Bruner/Mazel: New York (1998). Lewis DA, Sesack SR, Levey AI, Rosenberg DR: Dopamine axons in primate prefrontal cortex: Specificity of distribution, synaptic targets and development. In: Advances in Pharmacology (1998); 42: 703-706.

20

Fitzgerald K, MacMaster FP, Rosenberg DR: Neurobiology of childhood OCD. In: Scahill L and King R, eds. Obsessive Compulsive Disorders in Children and Adolescents. Child and Adolescent Psychiatric Clinics of North America. W.B. Saunders Company, Philadelphia (1999), 8 (3): 533-575. Rosenberg DR, Paulson L, MacMaster FP, Moore GJ: New frontiers in brain imaging of childhood onset anxiety disorders. In: Ernst M and Rumsey J, eds. The Foundation and Future of Functional Neuroimaging in Child Psychiatry. Cambridge University Press, New York (2000) pp. 224-241. Rosenberg DR, MacMillan S: Imaging and neurocircuitry of OCD. In: KL Davis, CB Nemeroff, J Coyle & D. Charney, ed.s. Neuropsychopharmacology: The 5th Generation of Progress. Lippincott Williams & Wilkins, Baltimore (2002), pp. 1621-1646. Pediatric Neuroimaging Group: Schultz R, Rosenberg DR, Pugh K, Pine D, Peterson B, Kaufman J, Kates W, Jacobsen L, Giedd J, Castellanos X, Anderson A: Pediatric neuroimaging. Ed: Lewis M. In: Textbook of Child & Adolescent Psychiatry: A Comprehensive Textbook. Baltimore, Lippincott Williams & Wilkins (2002), pp. 132-154. Rosenberg, DR, Davanzo P, Gershon S: Pharmacotherapy for Child and Adolescent Psychiatric Disorders: Second Edition, Revised and Expanded. Marcel Dekker, Inc. (2002). Farchione TR, MacMillan SN, Rosenberg DR: Obsessive compulsive disorder as a fronto-striatal-thalamic dysfunction. In: Bedard MA, Agid Y, Chouinard S, Fahn S, Korczyn A, Lesperance P, ed.s. Mental and Behavioral Dysfunction in Movement Disorders. Humana Press (2003), 477-488. Farchione TR, MacMillan SN, Rosenberg DR. Anxiety disorders in childhood and adolescence - basic mechanisms and therapeutic interventions. In: Soares JC, Gershon S, eds. Handbook of Medical Psychiatry. New York: Marcel Dekker, Inc. (2003), 175-196. Kreipke C, Rosenberg DR, Keshavan MS: Does disordered brain development cut across diagnostic boundaries? In: Keshavan MS, Kennedy JL, Murray R, ed.s. Neurodevelopment and Schizophrenia. Cambridge University Press, New York, (2004), 390-414. Fitzgerald KD, Rosenberg DR: Neuroimaging in child and adolescent psychiatry. In: Kaplan and Saddock V, eds. Comprehensive Textbook of Psychiatry. 8th edition. Philadelphia: Lippincott, Williams, and Wilkins (2005); 3519-3536. Rosenberg DR, Russell A, Fougere A (reply to chapter by Shafran on Cognitive and Behavioral Models of OCD): Biological and cognitive models of OCD: Seeking similarities and achieving progress together; Neuropsychiatric models of obsessive-compulsive disorder. In: Abramowitz JS, Houts AC, ed.s. Handbook of OCD: Concepts and Controversies. Springer-Verlag New York Inc., (2005) 209-228. Coffey CE, Brumback RA, Rosenberg DR, Voeller KS: Pediatric neuropsychiatry. Lippincott Williams & Wilkins (2005). Editing 8 chapters (Chapters 8-15). Rosenberg DR, MacMaster FP, Mirza Y, Easter PC, Buhagiar CJ: Neurobiology, neuropsychology and neuroimaging of child and adolescent obsessive-compulsive disorder . In: A Comprehensive Handbook of Child and Adolescent Obsessive-Compulsive Disorder. Lawrence Erlbaum Associates (2007), 131-161. MacMaster F, Rosenberg DR: Neuroimaging in psychiatry. In: Sadock BJ, Kaplan VA, ed.s. Comprehensive Textbook of Psychiatry. 9th edition. Lippincott Williams & Wilkins, New York. (2009) 3412-3431. MacMaster F, Rosenberg DR: Neuroimaging Studies of Pediatric Obsessive–Compulsive Disorder: Special Emphasis on Genetics and Biomarkers. In: Ritsner M, ed. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes, Volume II: Neuroanatomical and Neuroimaging Endophenotypes and Biomarkers. Springer Science (2009), 201-213.

21

Michalopoulou G, Falzarano P, Arfken C, Rosenberg D: Developments in cultural competency research. In: Ryan E, ed. Health Psychology. Murphy Nova Science Publishers, Ind. (2010), 39-60. MacMaster FP, Rosenberg DR, Kaufman J: Neurobiology of early-onset mood disorders. In: Martin A, Scahill L and Kratochvil C, ed.s. Pediatric Psychopharmacology: Principles and Practice, 2nd Edition. Oxford University Press, New York (2010), 124-138. Rosenberg DR, Vandana P, Chiriboga J: Anxiety disorders. Chapter 23, In: Nelson Textbook of Pediatrics. 19th ed. Philadelphia: Saunders, (2011) pp. 77-82. Rosenberg DR, Gershon S (Eds): Pharmacotherapy for Child and Adolescent Psychiatric Disorders, Third Edition, Wiley-Blackwell, United Kingdom. (2012). Rosenberg DR, Easter PC, Michalopoulou G: Brain Imaging. In: Zohar J, ed. OCD: Current Science and Clinical Practice. Wiley-Blackwell Publishing, Hoboken (2012), pp. 244-276. Michalopoulou G, Falzarano P, Arfken C, Rosenberg D: Developments in Cultural competency Research, Chapter 2. In: Psychology of Trust. Nova Science Publisher 2012; 37-58. Michalopoulou G, Falzarano P, Arfken C, Rosenberg D: Trust in the medical interaction: Implications for African American patients. In: Psychology of Trust. Nova Science Publisher 2011; 75-95. Chang S, O'Neil J, Rosenberg DR: Intervention of Neuropsychological Assessment and Clinical Intervention in Youth with OCD. In: Reddy, Hale, Weissman, ed.s. Neuropsychological Assessment and Intervention for Emotional and Behavior Disordered Youth: An Integrated Step-by-Step Evidence Based Approach. American Psychological Association Press. (2013), pp. 41-72. Wu K, Hanna GL, Easter P, Kennedy JL, Rosenberg DR, Arnold P: Glutamate system genes and brain volume alterations in pediatric obsessive-compulsive disorder: A Preliminary Study. Psychiatry Research: Neuroimaging. 2013; 211(3):214-20. Rosenberg DR: Obsessive Compulsive Disorder in Children and Adolescents. In: Hermann R, ed. Submitted to UpToDate, Waltham, MA. In Revision. MacMaster FP, Sembo M, Rosenberg DR: Neuroimaging in Psychiatric Disorder of Childhood. In: Kaplan and Saddock V, eds. “Comprehensive Textbook of Psychiatry, Philadelphia: Lippincott, Williams, and Wilkins. In Press. Rosenberg DR, Chiriboga J: Anxiety disorders. Chapter 25, In: Nelson Textbook of Pediatrics. 20th ed. Philadelphia: Saunders, 2015. MacMaster F, Rosenberg DR: Neuroimaging in psychiatry. In: Sadock BJ, Kaplan VA, ed.s. Comprehensive Textbook of Psychiatry. 10th edition. Lippincott Williams & Wilkins, New York. In Press. Rosenberg DR, Chiriboga J: Invited to Submit chapter on Anxiety Disorders: In Nelson Textbook of Pediatrics for 21st edition Abstracts Gilbert AR, Keshavan MS, Diwadkar V, Birmaher B, Nuche J, Russell A, Rosenberg DR: Abnormal brain maturational trajectories in pediatric obsessive-compulsive disorder (OCD) patients and high risk siblings of OCD patients. Biological Psychiatry, 2005. MacMaster FP, Carrey N, Rosenberg DR: Pituitary gland volume in treatment-naive pediatric mental illness. Supplement, Biological Psychiatry, 57: 199S, 2005.

22

MacMaster FP, Carrey N, Rosenberg DR: The effect of methylphenidate on striatal creatine in treatment naïve pediatric attention deficit hyperactivity disorder. New Clinical Drug Evaluation Unit Program, 45: 337, 2005. Easter PC, Buhagiar CB, MacMaster FP, Rosenberg DR: Structural variations in pediatric obsessive compulsive disorder: A voxel based analysis. Neuroimage, 26: 1-104, 2005. Arnold P, Kennedy JL, Hanna G, Sicard T, Burroughs E, Richter M, Rosenberg DR: NMDA candidate genes and neuroimaging phenotypes in pediatric obsessive-compulsive disorder. American Academy of Child and Adolescent Psychiatry (AACAP)/Canadian Academy of Child and Adolescent Psychiatry 2005 Joint Annual Meeting Scientific Proceedings, 32:170, 2005. El-Sheikh RM, MacMaster FP, Upadhyaya AR, Nutche J, Rosenberg DR, Keshavan MS: Specific effect of antipsychotics on pituitary volume: A structural MRI study. Supplement, Biological Psychiatry, 57: i-S223, 2005. Buhagiar C, Easter P, MacMaster FP, Rosenberg DR: Gray and white matter development in childhood and adolescence. Annual Meeting of the Michigan Society for Neuroscience, May 20, 2005. Schiavone A, MacMaster FP, Rosenberg DR: The effect of sedation on brain metabolites in pediatric psychiatric sample. Annual Meeting of the Michigan Society for Neuroscience, May 20, 2005. Easter P, Buhagiar C, MacMaster F, Rosenberg DR: A voxel based analysis of treatment effects in pediatric obsessive-compulsive disorder. Annual Meeting of the Michigan Society for Neuroscience, May 20, 2005. Niba R, Smith J, Russell A, Buhagiar C, Schiavone A, Kmiecik L, Easter P, MacMaster F, Rosenberg DR: Changes in brain volume in patients with OCD and MDD compared to normal healthy individuals. Research day presentation organized for Wayne State students in the NIMHCOR (National Institute of Mental Health Career Opportunities). MacMaster FP, Carrey C, Rosenberg DR: Reproducibility of proton magnetic resonance spectroscopy in children. ISMRM workshop on MR Spectroscopy for Neuropsychiatric Disorders, 2005. MacMaster FP, Carrey C, Rosenberg DR: The effect of methylphenidate on striatal creatine in treatment naïve pediatric ADHD. ISMRM workshop on MR Spectroscopy for Neuropsychiatric Disorders, 2005. MacMaster FP, Carrey C, Rosenberg DR: The effect of methylphenidate on striatal creatine in treatment naïve pediatric ADHD. New Clinical Drug Evaluation Program, 2005. Mirza Y, O'Neill J, Smith E, Russell A, Smith J, Banerjee SP, Bhandari R, Boyd C, Rose M, Ivey J, Renshaw PF, Rosenberg DR: Increased medial thalamic creatine/phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. Clinical EEG & Neuroscience, 36: 253, 2005. Gilbert AR, Szeszko P, Dailila A, Fitzgerald K, Lawrence N, Arnold P, Phillips M, Rosenberg DR: Translational approach to neural system abnormalities in obsessive-compulsive disorder: From structure to function. Biological Psychiatry. 2006; 59: 935. Matsuo K, Rosenberg D, Hua-Hsuan C, Caetano S, Hatch JP, Nicolleti M, Soares JC: Abnormal striatum in medication-naive pediatric unipolar depression patients. Biological Psychiatry 2006; 59: 189S, 617. Mirza Y, MacMaster FP, Kipp H, Greisenegger E, Bukstein O, Buhagiar CJ, Schiavone A, Kmiecik L, Easter P, Keshavan M, Rosenberg DR, Stanley JA: Brain Morphology in children with comorbid and non-comorbid attention-deficit/hyperactivity disorder. Biological Psychiatry, 2006; 59: 235S, 770.

23

MacMaster FP, Mirza Y, Szeszko P, Kmiecik L, Easter PC, Taormina SP, Boyd C, Lynch M, Rose M, Ivey J, Gerhardstein R, Moore GJ, Rosenberg DR: Amygdala and hippocampal volumes in familial pediatric major depressive disorder. Biological Psychiatry, 2006; 59: 138S, 449. Mirza Y, Keshavan M, Haefner J, Rosenberg DR: Do ADHD patients with familial risk for psychopathology have a higher likelihood of adverse effects with stimulants? Biological Psychiatry, 2006; 59: 155S, 503. MacMaster FP, Keshavan M, Mirza Y, Carrey N, Upadhyaya AR, El-Sheikh R, Buhagiar CJ, Taormina SP, Boyd C, Lynch M, Rose M, Ivey J, Moore GJ, Rosenberg DR: Development and sexual dimorphism of the pituitary gland. Biological Psychiatry, 2006; 59: 34S, 111. Kmiecik L, MacMaster FP, Rosenberg DR: The effect of treatment for pediatric major depression on hippocampal and amygdala volume. Biological Psychiatry, 2006; 59: 130S, 422. Easter PC, MacMaster FP, Mirza Y, Buhagiar CJ, Rosenberg DR: A voxel based analysis of treatment effects in pediatric obsessive-compulsive disorder. Biological Psychiatry 2006; 59: 235S, 769. Schiavone A, MacMaster FP, Rosenberg DR: The effect of sedation on brain metabolites in a pediatric psychiatric sample. Biological Psychiatry 2006; 59: 44S 143. Russell A, MacMaster FP, Easter P, Taormina SP, Boyd C, Rose M, Ivey J, Rosenberg DR: Reduced medial temporal cortex N-acetyl-aspartate using proton MRS in pediatric major depression. Biological Psychiatry 2006; 59: 44S, 141. Buhagiar CJ, MacMaster FP, Mirza Y, Taormina SP, Boyd C, Lynch M, Rose M, Ivey J, Rosenberg DR: A voxel based morphometry study of gray and white matter development during childhood and adolescence. Biological Psychiatry 2006; 59: 43S, 140. Rajarethinam RP, Peethala R, Jenrow A, Phan KL, Rosenberg DR, Keshavan M: Reduced activation of superior temporal gyrus in young non psychotic offspring of schizophrenia patients during listening. Biological Psychiatry 2006; 59: 255S, 836. Szeszko PR, Lencz T, Christian C, MacMaster F, Easter P, Rosenberg DR: Voxel-based morphometry predictors of treatment response in psychotropic-drug naïve pediatric patients with OCD. Supplement, Neuropsychopharmacology; 2006; 31: 41: S214. Arnold PD, Sicard T, Burroughs E, MacMaster FP, Mirza Y, Taormina P, Boyd C, Lynch M, Ivey J, Rose M, Richter MA, Kennedy JL, Rosenberg DR. A candidate gene study of thalamic volume in pediatric obsessive-compulsive disorder. Supplement, Neuropsychopharmacology; 2006; 31: 69: S225. Lucas T, Bhandari R, Cunningham W, Falzarano P, Hairston E, Menon S, Mosley R, Rosenberg D, Michalopoulou G: Recognition and reduction of the effects of health care disparities on medical eligibility. Institute of Mental Health Organizational Symposium, McGregor Memorial Conference Center, Detroit, MI, September 8, 2006. Falzarano P, Lucas T, Mosley R, Cunningham W, Menon S, Hairston E, Bhandari R, Rosenberg D, Michalopoulou G: Recruitment of minority participants for obsessive compulsive disorder treatment research. Institute of Mental Health Organizational Symposium, McGregor Memorial Conference Center, Detroit, MI, September 8, 2006. Lucas T, Bhandari R, Cunningham W, Falzarano P, Hairston E, Menon S, Mosley R, Rosenberg D, Michalopoulou G: Recognition and reduction of the effect of health care disparities on MedicAid eligible patients. Wayne State University-Children's Hospital of Michigan Child/Pediatric Conference, September 27-28, 2006.

24

Szeszko PR, Betensky J, Christian C, Lencz T, Malhotra AK, Robinson D, MacMaster FP, Mirza YM, Rosenberg DR: Increased grey matter in obsessive-compulsive disorder: Evidence from two optimized voxel based morphometry studies. Biological Psychiatry 2007; 59; p 93S. MacMaster FP, Leslie R, Kusumakar V, Rosenberg DR: Regional brain morphology in pediatric unipolar and bipolar depression. Biological Psychiatry 2007; 61: 26S. Arnold PD, Burroughs TSE, MacMaster FP, Mirza Y, Smith JM, Banerjee SP, Bhandari R, Boyd C, Lynch M, Ivey J, Rose M, Richter MA, Kennedy JL, Rosenberg DR: Association of a glutamate transporter gene (SLC1A1) with thalamic volume in pediatric obsessive compulsive disorder. Harvey Stancer Day Psychiatry Research Day, University of Toronto Psychiatry Research Conference, May 11, 2007. Arnold PD, Sicard T, Burroughs TSE, MacMaster FP, Mirza Y, Taormina SP, Boyd C, Lynch M, Ivey J, Rose M, Richter MA, Kennedy JL, Rosenberg DR. Glutamate system genes in pediatric obsessive-compulsive disorder: An imaging genetics study using magnetic resonance spectroscopy, Harvey Stancer Day, University of Toronto Psychiatry Research Conference, May 11, 2007. Arnold PD, Sicard T, Hanna G, Pato C, Pato M, Richter M, Rosenberg DR, Kennedy J: The glutamate system in OCD: A combined genetics-imaging approach. Scientific Proceedings of the 54th Annual Meeting of the American Academy of Child and Adolescent Psychiatry. Rosenberg DR, MacMaster F, Mirza Y, Szeszko P: Neuroimaging of the glutamate systems in pediatric OCD. Supplement, Neuropsychopharmacology. Submitted Gray H, Rosenberg DR: Cost-effective and efficient emergency psychiatric care in an urban children’s hospital. Annual Meeting of the National Association of Children's Hospitals and Related Institutions, San Antonio, TX, October 7-10, 2007. Arnold PD, Sicard T, Burroughs E, MacMaster FP, Mirza Y, Taormina SP, Boyd C, Lynch M, Ivey J, Rose M, Richter MA, Kennedy JL, Rosenberg DR. Glutamate system genes in pediatric obsessive-compulsive disorder: An imaging genetics study using magnetic resonance spectroscopy. Submitted to World Congress of Psychiatric Genetics meeting. Pine D, Peterson B, Gore J, Eden G, Giedd JN, Nelson CA, Piven J, Rapoport JL, Rosenberg DR, Sweeney JA: The future of neuroimaging: Relevance for child psychiatry. Scientific Proceedings of the Annual Meeting of American Academy of Child and Adolescent Psychiatry 2007; XXXIV, 3. Arnold PD, Richter M, Sicard T, Hanna G, Pato C, Pato M, Rosenberg D, Kennedy J: Genetics of OCD. Scientific Proceedings of the Annual Meeting of American Academy of Child and Adolescent Psychiatry 2007; XXXIV, 20C, 76. Rosenberg DR, MacMaster F, Szeszko P, Mirza Y, Arnold P, Moore G: Biomarkers in pediatric OCD. Scientific Proceedings of the Annual Meeting of American Academy of Child and Adolescent Psychiatry 2007; XXXIV, 26; 85-86. Geller DA, Rosenberg D, Hanna G, Bloch M, Rosario MC: New research in pediatric OCD. Scientific Proceedings of the Annual Meeting of American Academy of Child and Adolescent Psychiatry 2007; XXXIV; 26, 85. MacMaster FP, Easter P, Rix C, Kmiecik L, Buhagiar C, Rosenberg D: Regional volumetric changes with treatment in pediatric major depression. Biological Psychiatry 2008, 63:99. Arnold PD, MacMaster FP, Hanna GL, Richter MA, Sicard T, Burroughs E, Mirza Y, Easter PC, Rose M, Kennedy JL, Rosenberg DR: A candidate gene study of the anterior cingulate cortex (ACC): A putative intermediate phenotype in OCD. Obsessive Compulsive Foundation Genetic Collaborative Meeting, 2009.

25

Arnold PD, MacMaster FP, Hanna GL, Richter MA, Sicard T, Burroughs E, Mirza Y, Easter PC, Rose M, Kennedy JL, Rosenberg DR: Obsessive-compulsive disorder: Study of a complex psychiatric trait using putative neuroimaging intermediate phenotypes. 7th Annual Meeting of the Complex Trait Consortium, Montreal, Quebec, Canada, 2009. Vora A, Easter PC, MacMaster FP, Rosenberg DR: Orbital frontal white matter volume in obsessive-compulsive disorder. 4th Annual Wayne State University School of Medicine Medical Student Research Symposium, 2009. Haddad J, MacMaster FP, Easter P, Rix C, Fallucca E, Dick R, Stanley JA, Rosenberg DR: Cortical thickness in treatment naïve pediatric major depression. 4th Annual Wayne State University School of Medicine Medical Student Research Symposium, 2009. Silwanowicz R, MacMaster FP, Easter P, Rix C, Fallucca E, Dick R, Stanley JA, Rosenberg DR: The effect of medication on cortical thickness in pediatric patients with obsessive-compulsive disorder. 4th Annual Wayne State University School of Medicine Medical Student Research Symposium, 2009. Rosenberg DR, MacMaster FP, Szeszko P, Easter, PC, Caton M: Examining the glutamate hypothesis of pediatric OCD with neuroimaging and genetics: “Mechanisms of treatment response in pediatric OCD”, Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Florida, December 10, 2009. Michalopoulou G, Falzarano P, Arfken C, Rosenberg DR: Pilot implementing Ask Me 3™ to improve African American patient satisfaction and perceptions of physician cultural competency. 5th Annual Wayne State University School of Medicine Department of Psychiatry and Behavioral Neurosciences Research Day, Detroit, MI, April 30, 2010. Pareek P, Silwanowicz R, MacMaster FP, Easter PC, Rix C, Rosenberg DR: The effect of treatment on cortical thickness in pediatric obsessive compulsive disorder. 5th Annual Wayne State University School of Medicine Department of Psychiatry and Behavioral Neurosciences Research Day, Detroit, MI, April 30, 2010. Easter PC, MacMaster FP, Rix C, Rosenberg DR: Neuroimaging genetics in pediatric obsessive compulsive disorder. 5th Annual Wayne State University School of Medicine Department of Psychiatry and Behavioral Neurosciences Research Day, Detroit, MI, April 30, 2010. Rix C, MacMaster FP, Easter PC, Rosenberg DR: Hippocampal volume in pediatric mood disorders. 5th Annual Wayne State University School of Medicine Department of Psychiatry and Behavioral Neurosciences Research Day, Detroit, MI, April 30, 2010. Khatib D, Dick R, McGarragle O, MacMaster F, Robin A, Diwadkar D, Rosenberg DR, Stanley JA: Evidence of age effects in cortical areas but not in the subcortex of ADHD children using 31P MRS. 5th Annual Wayne State University School of Medicine Department of Psychiatry and Behavioral Neurosciences Research Day, Detroit, MI, April 30, 2010. Gilbert AR, Almeida J, Akkal D, Mataix-Cols D, Rosenberg D, Phillips ML: Neural imaging markers for OCD in children and adolescents. Biological Psychiatry 2010: 67: 375S. Martis B, Khatib D, Dick R, McGarragle O, MacMaster F, Rosenberg D, Diwadkar V, Stanley J: A multi-voxel in vivo 31P spectroscopy study at 4 Tesla in healthy children and adolescents. Biological Psychiatry 2010; 67: 429S. Zai G, Arnold PA, Rosenberg D, Kennedy JL, Richter MA: Genetic analyses of the myelin oligodendrocyte glycoprotein (MOG) and oligodendrocyte lineage transcription factor 2 (OLIG2) genes with white matter volume in OCD. World Congress on Psychiatry Genetics (WCPG) 2010.

26

Arnold P, Wu K, MacMaster F, Easter P, Kennedy J, Hanna G, Rosenberg D: The association between glutamate system genes and brain volume alterations in children with OCD. Scientific Proceedings of the American College of Neuropsychopharmacology, 2010. Zai G, Arnold PD, Richter MA, Hanna GL, Rosenberg DR, Kennedy JL: Genetics analyses of the myelin oligodendrocyte glycoprotein (MOG) and oligodendrocyte lineage transcription factor (Olig2) genes with white matter volume in obsessive-compulsive disorder. Biological Psychiatry, 2011; 267: 78S. Diwadkar VA, Radwan J, Mashadi MR, Khatib D, McGarragle O, Pruitt PJ, Robin A, Rosenberg DR, Stanley JA: The cortico-striatal response during sustained attention in children with ADHD: fMRI evidence of developmental deviation. Biological Psychiatry, 2011: 271: 80S. Easter P, MacMaster FP, Rosenberg DR: Change in pituitary volume in pediatric patients with obsessive compulsive disorder after treatment. Research Day Book of Abstracts, Wayne State University School of Medicine, Detroit, MI, May 6, 2011. Mohl BM, Goaradia D, Khatib D, Dick RM, Benitez-Zajac C, Rosenberg DR, Rajan U, McGarragle O, Stanley JA: Association fibers show increased FA in boys with ADHD. Research Day Book of Abstracts, Wayne State University School of Medicine, Detroit, MI, May 6, 2011. Rix C, Easter P, Wing M, Szeszko P, Rosenberg DR: Do gray matter structural alterations in psychotropic-drug naive pediatric obsessive compulsive disorder patients predict treatment response and clinical remission? Research Day Book of Abstracts, Wayne State University School of Medicine, Detroit, MI, May 6, 2011. White R, Radwan J, Mashhadi MR, Khatib D, McGarragle O, Pruitt PJ, Robin A, Rosenberg DR, Stanley JA, Diwadkar V: The cortico-striatal response during sustained attention in children with ADHD: fMRI evidence of developmental deviation. Research Day Book of Abstracts, Wayne State University School of Medicine, Detroit, MI, May 6, 2011. Rosenberg D: Mechanisms of treatment response in pediatric obsessive compulsive disorder. Scientific Proceedings of American Academy of Child and Adolescent Psychiatry 2012; XXXIV; S46.2, 145. Alberti SL, Swartz JR, Smith D, Wiggins JL, Easter P, Rosenberg DR, Lord C, Monk CS: Increased amygdala volume relates to social anxiety in children and adolescents with autism spectrum disorders. Association for Psychological Science Annual Convention, Washington, D.C., May 23-26, 2013. von Gunten H, Cichon T, Easter P, Rix C, Wing M, Szeszko P, Rosenberg DR: Gray matter structural alterations in psychotropic drug naive pediatric obsessive compulsive disorder patients predict treatment response and clinical remission. Research Day Book of Abstracts, Wayne State University, School of Medicine, Detroit, MI, March 1, 2013, page 36. Zai G, Arnold PD, Richter MA, Hanna GL, Rosenberg DR, Kennedy JL: White matter volume and genetic analyses of the myelin oligodendrocyte glycoprotein (MOG) and oligodendrocyte lineage transcription factor 2 (OLIG2) genes in patients with pediatric obsessive-compulsive disorder. Supplement, The XIXth World Congress of Psychiatric Genetics. Other Rosenberg DR: OCD in Children and Adolescents: A Cognitive Behavioral Treatment Manual, by John S. March and Karen Mulle, Guilford Press, New York, 1998, 298 pp. Depression and Anxiety, 1999; 9:149. Rosenberg DR: Sensorimotor Control, by Dengler, Reinhard, Kosseu, Andon R (ed). IOS Press, Amsterdam, Netherlands, 2001, 221 pp. Contemporary Psychology 2002. Rosenberg DR: The use and misuse of psychiatric drugs, by Joel Paris. Reviewed for Wiley-Blackwell.

27

Presentations INVITED LECTURES/PRESENTATIONS International/national meetings Developmental shifts in the dopaminergic innervation of monkey prefrontal cortex. 48th Annual Meeting of the Society of Biological Psychiatry, San Francisco, CA, May, 1993. The application of a sensitive and specific in vivo cognitive probe to test hypotheses generated in the basic science laboratory. Psychiatric Grand Rounds, University of Pennsylvania, February 22, 1994. Bridging the basic science-clinical interface with functional magnetic resonance imaging. Grand Rounds, Columbia University, April 15, 1994. Functional magnetic resonance imaging studies of cognition in pediatric populations. American Academy of Child and Adolescent Psychiatry, 41st Annual Meeting, New York, NY, October, 1994. Developmental neurobiology: The basic science-clinical interface. Psychiatric Grand Rounds, University of California, Los Angeles, CA, January 12, 1995. Eye-tracking dysfunctions in offspring from the New York high risk project. Society of Biological Psychiatry, 50th Annual Convention & Scientific Program, Miami, FL, May 17-21, 1995. MRI studies of neurobehavioral response inhibition. Cognitive Neuroscience Colloquium, University of Pittsburgh Medical Center, Pittsburgh, PA, September 15, 1995. Can penicillin and plasmapheresis cure obsessive compulsive disorder? Bridging the pediatric-psychiatric interface. Pediatric Grand Rounds, Children’s Hospital of Pittsburgh, Pittsburgh, PA, October 12, 1995. Consultant for Upjohn. The role of penicillin and plasmapheresis in pediatric obsessive compulsive disorder: The pediatric-psychiatric interface. Pediatric Grand Rounds, Mercy Hospital, Pittsburgh, PA, January 16, 1996. Consultant for Upjohn. Anxiety disorders and depression in adolescents. American Academy of Family Practice Physicians, Lake Placid, NY, January 27, 1996. Consultant for Upjohn. Post-traumatic stress disorder in adolescents. American Academy of Family Practice Physicians, Lake Placid, NY, January 27, 1996. Consultant for Upjohn. Fronto-striatal pathology of pediatric OCD: Implications for diagnosis and treatment. Psychiatric Grand Rounds, Allegheny General Hospital, Pittsburgh, PA, April 25, 1996. Consultant for Solvay. Cortico-striatal pathology of obsessive compulsive disorder: Diagnostic and therapeutic implications. Psychiatric Grand Rounds, Johns Hopkins University Medical Center, Baltimore, MD, July 12, 1996. The pharmacologic ABC’s of treating OCD in adults and children. National OCD Foundation Annual Conference, San Jose, California, September 7, 1996. Applications of functional brain imaging studies of neurocognitive and neurobehavioral development to the investigation of childhood-onset neuropsychiatric disorders. American Academy of Child and Adolescent Psychiatry Annual Conference, Philadelphia, PA, October 22-27, 1996.

28

Neuroanatomical abnormalities in pediatric obsessive compulsive disorder: Implications for abnormal developmental maturation of fronto-striatal circuitry. Society for Neuroscience, Washington, D.C., November 16-21, 1996. Toward a neurodevelopmental model of OCD. Society of Biological Psychiatry, San Diego, CA, May 14-18, 1997. Identification of critical windows of abnormal development in pediatric OCD. Child Psychiatry Grand Rounds, University of Alabama, Birmingham, Alabama, June 4, 1997. Applications of fMRI to the study of CNS effects of psychotropics, NIMH Workshop, Bethesda, Maryland, July 16, 1997. Imaging studies of childhood and adolescent obsessive compulsive disorder. OCD Symposium, University of Pittsburgh Medical Center, September 26, 1997. Consultant for Solvay Pharmaceuticals. OCD: The evolving view of a neurodevelopmental disorder. Symposium, American Academy of Child and Adolescent Psychiatry, Toronto, Ontario, Canada. October 14-19, 1997. Augmentation therapy in obsessive compulsive disorder. Indianapolis Child and Adolescent Psychiatry Association, Indianapolis, Indiana, May 14, 1998. Consultant for Solvay Pharmeceuticals. Use of lithium in child and adolescent psychiatry. Indianapolis Child and Adolescent Psychiatry Association, Indianapolis, Indiana, May 14, 1998. Striatal glutamatergic changes and treatment response in pediatric obsessive compulsive disorder, Symposia 5, “In vivo neurochemistry of anxiety”, Society of Biological Psychiatry, 53rd Annual Scientific Convention and Program, Toronto, Ontario, Canada, May 27, 1998. Proton magnetic resonance spectroscopic measurement of caudate glutamatergic changes associated with paroxetine therapy for pediatric obsessive compulsive disorder. Psychopharmacologist Competition, XX1st meeting of the International Congress of Neuropsychopharmacology (CINP), Glasgow, Scotland, July 15, 1998. There were 68 applicants for this award. 3 finalists were chosen to present their work, followed by questioning from the panel first and secondly the audience and were judged by a panel on scientific quality, clarity of thought, clarity of expression and ability to deal with questions. I was declared the outright winner of this competition. Volumetric and morphometric studies in Tourette’s syndrome, National Tourette’s Syndrome Foundation meeting, Boston, Massachusetts, August 14, 1998. New advances in pediatric OCD, Third International Obsessive Compulsive Disorders Congress, Madeira, Portugal, September 11, 1998. Consultant for Solvay Pharmaceuticals. New advances in pediatric OCD, Third International Obsessive Compulsive Disorders Congress, Madeira, Portugal, September 11, 1998. Consultant for Solvay Pharmaceuticals. Brain neurochemistry in pediatric obsessive compulsive disorder, Third International Congress for Obsessive Compulsive Disorders Conference, Madeira, Portugal, September 11-12, 1998. Striatal glutamate and treatment response in pediatric OCD: The search for biological markers: NIMH Workshop Committee: Surrogate end points/marker workshop in pediatrics, September 1998. MRS studies in pediatric OCD. Study group, “MRS studies of brain biochemistry during childhood in health and in neuropsychiatric illness” (Bruce Cohen, Chair; Perry Renshaw, Moderator), American College of Neuropsychopharmacology, Las Croabas, Puerto Rico, December 14, 1998.

29

Brain imaging in anorexia nervosa and obsessive compulsive disorder. Study Group, “Anorexia nervosa and obsessive compulsive disorder (OCD) – Alternate expressions of a common biology?” (Walter Kaye, Chair, James Leckman, Moderator), American College of Neuropsychopharmacology, Las Croabas, Puerto Rico, December 15, 1998. Study Section, 1-H MRS and treatment response in pediatric obsessive compulsive disorder. American College of Neuropsychopharmacology Annual Meeting, Puerto Rico, December 1998. Augmentation therapy in obsessive compulsive disorder. Toledo’s Child & Adolescents Pediatric Association, Toledo, Ohio, May 26, 1999. Use of lithium in child and adolescent psychiatry. Toledo’s Child & Adolescents Pediatric Association, Toledo, Ohio, May 26, 1999. Practical issues in conducting fMRI studies in children. NINDS-NIMH-NICHD Initiative, Xerox Center, Virginia, September 29-October 1, 1999. Toward a new developmental model for OCD, Psychiatry Grand Rounds, John Hopkins University, Baltimore, Maryland, October 6, 1999. New Frontiers in neuroimaging of childhood onset neuropsychiatric disorders, Institute, “Targets of pharmacotherapy.” From signs to symptoms to synopses. 46th Annual meeting American Academy of Child and Adolescent Psychiatry, Chicago, Illinois, October 19-24, 1999. Toward a neurodevelopmental model of OCD. 46th Annual meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, Illinois, October 19-24, 1999. Cortico-striatal-thalamic circuitry in OCD. The Annual Psychiatric Research Society Meeting. Park City, Utah, February 9-12, 2000. Depression in the twenty-first century: New insights into drug development and neurobiology. Society of Biological Psychiatry, Dana Point, California, February 21-22, 2000. Toward a neurodevelopmental model of OCD. Grand Rounds, University of Western Ontario, Toronto, Ontario, Canada, March 9, 2000. Pharmacogenetic imaging strategies: Implications for treatment. 30th National Conference Satellite Research Symposium, Anxiety Disorders Association of America, March 23, 2000. Obsessive compulsive disorder difficult case management. American College of Neuropsychiatrists Medical Mid-year Meeting and Scientific Seminar, Scottsdale, Arizona, March 29 – April 2, 2000. Keynote Speaker: Integration and translation of neuroimaging studies into clinical trials and treatment development. 7th Annual MCO Research Symposium, Medical College of Ohio, April 13, 2000. Striatal glutamatergic changes in OCD patients after pharmacotherapy. Symposium, Abnormal neurocircuitries in OCD. XXIInd Congress of the Collegium Internationale Neuro-Psychopharmacologicum, July 9-13, 2000. Brussels, Belgium. Treatment strategies for child and adolescent anxiety disorders. Indianapolis, Indiana, October 5, 2000. Neuroimaging and pediatric OCD. Pediatric Grand Rounds, University of Vermont, Burlington, Vermont, October 13, 2000. Neuroimaging in child psychiatry. Psychiatry Grand Rounds, Indiana University, Indianapolis, Indiana, January 19, 2000.

30

New advances in pediatric obsessive compulsive disorder. Psychiatry Grand Rounds, Children’s Hospital, Cincinnati, Ohio, April 9, 2003. Identification of biomarkers in pediatric OCD and depression. Psychiatry Grand Rounds, University of Cincinnati, Ohio, April 9, 2003. New advances in pediatric OCD. Grand Rounds, University Hospital of Cleveland, Ohio, April 13, 2001. Toward a Neurodevelopmental Model of OCD. Pediatric Grand Rounds, Children's Hospital Medical Center, Cincinnati, Ohio, May 29, 2001. Obsessive compulsive disorder. Psychiatry Grand Rounds, Centre for Addiction and Mental Health, Clarke University of Toronto, Toronto, Ontario, Canada, August 28, 2001. Obsessive compulsive disorders as a fronto-striatal dysfunction. Mental and Behavioral Dysfunction in Movement Disorders: An International Symposium, Montreal, Quebec, Canada. October 11, 2001. Pediatric OCD. Centre of Addiction and Mental Health - Clarke Site, Toronto, Ontario, Canada, August 28, 2001. Neurobiological markers of treatment response in pediatric OCD. Invited lecture, Symposium, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Honolulu, Hawaii, October 25, 2001. Decrease in caudate glutamatergic concentrations in pediatric OCD patients taking paroxetine - The Reiger Award. Invited lecture, Honors Presentation, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Honolulu, Hawaii, October 27, 2001. Keynote Address for the Second Annual Western Psychiatric Institute and Clinic Research Day, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, June 18, 2002. MRS, glutamate and OCD. The First Arvid Carlssohn Symposium in Gothenburg, Sweden, September 28, 2002. Mechanisms of treatment response in pediatric obsessive compulsive disorder. Panel Symposium, “Recent advances in pediatric obsessive compulsive disorder?”, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, California, October 25, 2002. Frontal-striatal glutamate and treatment response in pediatric OCD. Panel Symposium, “What are the neural substrates for OCD?”, Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 9, 2002. Speaker on imaging/cortico-striatal-thalamic circuitry in OCD, Symposium on Current Concepts Regarding the Etiology of OCD, Anxiety Disorders Association of America (ADAA), Toronto, Ontario, Canada, March 28, 2003. Speaker on pharmacological treatments of OCD, Symposium on Psychological and Medical Treatments for Children with OCD, Anxiety Disorders Association of America (ADAA), Toronto, Ontario, Canada, March 29, 2003. Speaker on identification of biomarkers in pediatric OCD, Symposium on Psychological and Medical Treatments for Children with OCD, Anxiety Disorders Association of America (ADAA), Toronto, Ontario, Canada, March 29, 2003.

31

Speaker on identification of relevant biomarkers in pediatric OCD and depression, Symposium on Brain Imaging Markers of Pharmacological Treatment, New Clinical Drug Evaluation Unit (NCDEU), Boca Raton, Florida, May 29, 2003. Functional neuroimaging and OCD. Child & Adolescent Psychiatry Grand Rounds, Oregon Health & Science University, Portland, Oregon, June 20, 2003. Belated recognition: Catching up with the rest of the medical profession. Child & Adolescent Psychiatry Graduation, Oregon Health & Science University, Portland, Oregon, June 20, 2003. Identification of relevant biomarkers in childhood onset neuropsychiatric disorders: Implications for improved diagnosis and treatment. Oregon Council of Child & Adolescent Psychiatry, Portland, Oregon, June 21, 2003. Toward the identification of relevant biomarkers in pediatric OCD and depression. Symposium chaired by Dr. Daniel Pine for Childhood Depression Consortium Meeting, Pittsburgh, Pennsylvania, September 22, 2003. Mechanisms of treatment response in pediatric OCD and depression. Panel Symposium, “Neuroimaging of Treatment Responses” (Dr. Judith Rumsey, chair), Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Miami Beach, Florida, October 17, 2003. Developmental alterations in pediatric obsessive compulsive disorder. Panel Symposium, “Update on Pediatric Obsessive Compulsive Disorder Research” (Dr. Daniel Geller, chair), Annual Meeting of the American Academy of Child & Adolescent Psychiatry, Miami Beach, Florida, October 17, 2003. Lecture on ADHD, Symposium, “Updates in Primary-Care-Issues in Psychiatry for the Primary Care Practitioner”, McLaren Regional Medical Center, Flint, MI. Symposium/workshop on the commonalities and differences between neurodevelopmental changes in neuropsychiatric disorders of child/adolescent onset. Society of Biological Psychiatry. Moderators and Co-chairs: Matcheri Keshavan, M.D. and David Rosenberg, M.D., New York, New York, April 29, 2004. Speaker on medications for ADHD at Children and Adults with Attention Deficit/Hyperactivity Disorder (CHADD) community forum “Building a Village: Accessing Tools to Bridge Resources”. Aug 28, 2004. 1H MRS in children with obsessive compulsive disorder, major depression and ADHD. MacMaster FP, Mirza Y, Rosenberg DR (2004). EEG and Clinical Neuroscience Society (ECNS) and the International Society for Neuroimaging in Psychiatry (ISNIP), Irvine, California, October 1, 2004. Lecture on psychopharmacological strategies for the management of treatment resistant obsessive compulsive disorder, Symposium, “Pharmacological Strategies for the Management of Children with Treatment Resistant Disorders”, 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, D.C., October 19, 2004. Chair and Speaker, Symposium, "MRI Studies of Childhood Disorders", 51ST Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Washington, DC, October 19-24, 2004. Lecture on functional neurochemical markers in pediatric OCD and depression, Symposium, 51st Annual Meeting of the American Academy of Child and Adolescent Psychiatry, October 23, 2004, Washington, D.C. Lecture on psychoactive drugs for Continuing Medical Education (CME) Course, “Drug Therapy in Children”. Conference on Drug Therapy in Children, Las Vegas, Nevada, April 8, 2005.

32

Psychoactive drugs for anxiety and depression. Conference on Drug Therapy in Children, Las Vegas, Nevada, April 8, 2005. Psychoactive drugs for autism. Conference on Drug Therapy in Children, Las Vegas Nevada, April 8, 2005. Lectures on Psychopharmacology of ADHD, Autism and Depression and Anxiety, April 8, 2005, for 55 Pediatricians, 11 Family Practitioners, 2 Pharmacy and 2 other health care professionals. On Scale of 1 (Strongly Disagree) to 4 (Strongly Agree), Knowledge of Topics = 4.0; Effectiveness of Presentation = 3.8; Content and level of material presented was appropriate for your needs = 3.7; Information provided was practical and can be applied to your professional needs = 3.6; Information presented will improve treatment of patients = 3.7. Ratings of objectives on a scale of 1 (Unsatisfactory) to 4 (Excellent); Have state-of-the-art knowledge on the drug therapies for attention deficit disorders and psychopharmacologic drugs in children 3.8; Know the current information on drug therapies in Autism = 3.7; Understand the pharmacologic management of childhood anxiety disorders = 3.6. Comments included "Dr. Whitley and Rosenberg-excellent speakers". Lecture for Psychiatry Grand Rounds at University of Mississippi Medical Center, Jackson, Mississippi, May 13, 2005. Expert Opinion Group regarding future classification of OCD and related disorders in DSM-V, 2006. Searching for biomarkers of treatment effects: Contributions from neuroimaging. NIMH Conference on Treating Children and Adolescents with Depression: What We Know, What Else We Need to Know Through Research, Washington, D.C., February 6, 2006. Moderated workshop on a translational approach to examining neural system abnormalities in OCD and its symptom dimensions across the lifespan at the 61st Annual Meeting of the Society of Biological Psychiatry, Toronto, Ontario, Canada, May 18-20, 2006. Biological Psychiatry Symposium, “Translational Approach to Neural System Abnormalities in Obsessive-Compulsive Disorder: From Structure to Function”; Rosenberg DR, chair of workshop symposium. 61st Annual Scientific Convention and Program, Society of Biological Psychiatry, Toronto, Ontario, Canada, May 19, 2006. Lecture on obsessive compulsive disorder. Duquesne University, Pittsburgh, Pennsylvania, February 22, 2006. Lecture on schizophrenia. Duquesne University, Pittsburgh, Pennsylvania, June 23, 2006. Lecture on generalized anxiety disorder. Duquesne University, Pittsburgh, Pennsylvania. June 23, 2006. Attended the NIH special emphasis panel on functional imaging in children and adolescents, August 2006. Symposium, “The Neurochemistry of Pediatric Neuropsychiatric Disorders”; Dr. Rosenberg, moderator, presenter, and discussant. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Diego, California, October 2006. Cost-effective and efficient emergency psychiatric care in an urban children’s hospital. Lecture with concurrent educational session, Annual Meeting of the National Association of Children's Hospitals and Related Institutions (NACHRI), San Antonio, Texas, October 10, 2007. Audience included approximately 25 physicians, pediatricians, social workers, nurses, administrators and residents/fellows. Ratings on scale of 1-5 (1 worst, 5 best). Expertise of presenter: 4.8; Content Presented was Clear and Organized 4.6; Instructional Aids Supported Presentation 4.6; Teaching Methods Facilitated Learning 4.2. Comments included "What a great resource for cost effective services"; "Excellent".

33

Research Forum, “Brain Imaging of Pediatric OCD”. Neuroimaging Symposium, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, October 23, 2007. Research Forum, “The Future of Neuroimaging: Relevance for Child Psychiatry”. Neuroimaging Symposium, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, October 23, 2007. New research in pediatric OCD. Annual Meeting of the American Academy of Child and Adolescent Psychiatry Annual Meeting, October 26, 2007. Symposium on the role of glutamate in obsessive compulsive disorder, “Neuroimaging of the glutamate systems in pediatric OCD”, submitted to American College of Neuropsychopharmacology Annual Meeting, Boca Raton, Florida, December 9-13, 2007. A clinical overview of the diagnosis and treatment of OCD and social anxiety disorder. Columbus, Ohio, June 12, 2008. A clinical overview of obsessive compulsive disorder and social anxiety disorder, lecture to clinic psychiatrists and psychologists, Toledo, Ohio, August, 20, 2008. NIMH-funded workshop, "Pharmacologically Treating Emotional and Behavioral Disturbances in Children: Engaging Controversies: The Neurobiology of Child and Adolescent Depression", Rockefeller University, New York, New York, December 1-2, 2008. NIMH Child Psychiatry Project Workshops, “Controversies around the diagnosis and treatment of child and adolescent depression”; “The neurobiology of child and adolescent depression”. The Hastings Center, New York, New York, December 1-2, 2008. Invited as site for Collaborative R01, "Trajectory of OCD in a Pediatric Sample (TOPS)” with Duke University, University of Pennsylvania, Brown University and UCLA. We are currently preparing application and analyzing preliminary data. New advances in pediatric obsessive compulsive disorder. Psychiatry Grand Rounds, Sick Kids (Hospital for Sick Children), University of Toronto, Toronto, Ontario, Canada, September 10, 2009. Attended by psychiatrists, psychiatry residents, research students, social workers, nurses, occupational therapists, psychologists. Ratings (Poor, Fair, Good, Very Good, Excellent): The presenter communicated in a clear, appropriate and well-organized manner, Very good 44%, Excellent 56%; The presentation met the stated objectives Very Good 33%, Excellent 61%; The topic was relevant, stimulating, thought-provoking, Very Good 28%, Excellent 72%; The AV aids enhanced the presentation, Very Good 33%, Excellent 67%; The time devoted to interactive learning was Very Good 50%, Excellent 50%. Comments included "Very clear presenter!", "Excellent presentation. Great balance of basic science research and clinical applications". "Found the brief video presentation very helpful in understanding the basic neural effect of this disease"; "Thank you! Very important work. Many children will learn to live again as a result". New advances in pediatric OCD. Grand Rounds, Zucker Hillside Hospital, Glen Oaks, New York, November 18, 2009. Chair of Panel Symposium, “Examining the Glutamate Hypothesis of Pediatric OCD with Neuroimaging and Genetics”, Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Florida, December 10, 2009. Mechanisms of treatment response in pediatric OCD. Annual Meeting of the American College of Neuropsychopharmacology, Hollywood, Florida, December 10, 2009.

34

Discussant and moderator for symposium, "Pediatric Generalized Anxiety Disorder: Relationships Between Development, Neurobiology, and Treatment”, Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York, New York, October 30, 2010. Mechanisms of treatment response in pediatric OCD. Lecture to Psychiatry Department, University of Wisconsin, Madison, Wisconsin, August 26, 2011. A new approach in child and adolescent psychiatry at WSU. Wayne State University and Alumni Initiatives, La Jolla, California, November 1, 2011. A new approach in child and adolescent psychiatry at WSU. Wayne State University and Alumni Initiatives, Beverly Hills, California, November 3, 2011. Mechanisms of treatment response in pediatric obsessive compulsive disorder. Panel Symposium, “Neuroimaging in Clinical Practice: Are We There Yet?” (Dr. Antonio Hardan, chair), Annual Meeting of the American Academy of Child & Adolescent Psychiatry, San Francisco, California, October 27, 2012. Frontal-Striatal-Thalamic Dysfunction in OCD: From Genes to Brain Structural and Dys-Functioning Brain Networks. Panel Symposium “Mechanisms of Treatment Response in Pediatric OCD” (Dr. Rosenberg, chair), Annual Meeting of the Society of Biological Psychiatry, New York, New York, May 10, 2014. Local/regional meetings Invited Presentation on Bench-to-Bedside Research in Child and Adolescent Psychiatry to Wayne State University Board of Visitors, Detroit, Michigan, March 13, 2009. Invited to speak at DMC Board of Trustees Meeting, Children’s Hospital of Michigan, July 28, 2009. Invited to speak at DMC Executive Management Team Meeting, August 5, 2009. Invited to speak at WSU University Research Corridor Congressional Tour, August 18, 2009. Academic Symposium honoring the presidential inauguration of Allan Gilmour, "A New Approach in Child Psychiatry", Wayne State University, Detroit, Michigan, April 15, 2011. Seminars and grand rounds Fronto-striatal pathology of childhood OCD. Psychiatric Grand Rounds, WSU, Detroit, MI, May 10, 1995. New advances in the diagnosis and treatment of obsessive compulsive disorders. Hawthorne Center, Novi, MI, January 14, 1997. Using medicine in children to treat obsessive compulsive disorder. Michigan OCD Self-Help Group, Dearborn, MI, January 16, 1997. New advances in the diagnosis and treatment of obsessive compulsive disorder. Hawthorne Center, Detroit, MI, January 16, 1997. A clinical neurodevelopmental model of OCD. Psychiatry Grand Rounds, WSU, Detroit, MI, January 22, 1997. Functional neuroimaging studies of cognition. WSU Brain Imaging Group, PET Center, Children’s Hospital, Detroit, MI, January 28, 1997. Tourette’s syndrome in the pediatric setting. Chairman’s Rounds, Department of Pediatrics, William Beaumont Hospital, Royal Oak, MI, February 28, 1997.

35

Diagnosis and treatment of obsessive compulsive disorder through the life cycle. Moderator and speaker for WSU Department of Psychiatry and Behavioral Neurosciences and Solvay Pharmaceuticals Symposium, Dearborn, MI, March 8, 1997. The role of penicillin and plasmapheresis in the treatment of autoimmune pediatric obsessive compulsive disorder. Pediatric Grand Rounds, Beaumont Hospital, Royal Oak, MI, April 8, 1997. Diagnosis and treatment of pediatric obsessive compulsive disorder. Child and Adolescent Obsessive Compulsive Disorder Conference (cosponsored by WSU, Michigan State University, the University of Michigan Departments of Psychiatry and the Michigan State Chapter of the National OCD Foundation), Novi, MI, April 8, 1997. New advances in the diagnosis and treatment of OCD. Psychiatric Grand Rounds, Sinai Hospital, Detroit, MI, May 21, 1997. Functional neuroimaging studies of substance abuse. WSU Clinical Research Division for Substance Abuse, Detroit, MI, May 27, 1997. New developments in OCD. WSU Department of Psychiatry and Behavioral Neurosciences meeting, Laurel Manor, Livonia, MI, June 13, 1997. Conversion disorder in the pediatric setting. Chairman’s Rounds, Department of Pediatrics, Beaumont Hospital, Royal Oak, MI, July 31, 1997. Management and treatment of psychiatric emergencies. Beaumont Hospital Emergency Room Staff, Royal Oak, MI, August 12, 1997. Brain Imaging: Implications on the diagnosis and treatment of neuropsychiatric disorders. Chairman, organizer of conference, and speaker. Dearborn, MI, September 20, 1997. The developmental neurobiology of OCD. Psychiatric Grand Rounds, University of Michigan, Ann Arbor, MI, October 1, 1997. Pharmacotherapy of childhood onset neuropsychiatric disorders in the pediatric setting. Pediatric Grand Rounds, WSU, Detroit, MI, November 21, 1997. A surgical approach to OCD. Neurosurgery Grand Rounds, WSU, Detroit, MI, December 17, 1997. Obsessive compulsive disorder. Pediatric Grand Rounds, Henry Ford Hospital, Detroit, MI, January 21, 1998. Conversion disorder. Pediatric Grand Rounds, William Beaumont Hospital, Royal Oak, MI, February 9, 1998. OCD treatment overview. Department of Psychiatry and Behavioral Neurosciences, Detroit Medical Center Staff and Clinical Faculty Meeting, Detroit, MI, March 4, 1998. Chairman and conference organizer, Eating Disorder Symposium. Children’s Hospital of Michigan, Detroit, MI, March 20, 1998. A neurodevelopmental model of OCD: Implications for diagnosis and treatment. Psychiatry Grand Rounds, Henry Ford Hospital, Detroit, MI, April 2, 1998. OCD and Tourette’s syndrome. Pediatric Grand Rounds, Beaumont Hospital, Royal Oak, MI, May 5, 1998.

36

Course director and speaker, Developmental Neuroimaging Symposium. Dearborn, MI, June 12, 1998. OCD in children and adolescents. Annual meeting of the Michigan Chapter of the American Academy of Pediatrics, Shanty Creek, MI, August 9, 1998. New advances in the diagnosis and treatment of Tourette’s syndrome. Annual meeting of the Michigan Tourette’s Syndrome Foundation, Royal Oak, MI, September 19, 1998. Symposium, “New Advances in the Diagnosis and Treatment of Childhood Onset Neuropsychiatric Disorders”; Dr. Rosenberg, Course Organizer, Chair and Speaker. Children’s Hospital of Michigan, Detroit, MI, September 25, 1998. New advances in the diagnosis and treatment of childhood OCD. Child Psychiatry Grand Rounds, Wayne State University School of Medicine, Detroit, MI, October 11, 1998. New advances in the diagnosis and treatment of pediatric conversion disorder. Pediatric Grand Rounds, William Beaumont Hospital, Royal Oak, MI, December 3, 1998. Consultant for Solvay Pharmaceuticals. Childhood obsessive compulsive disorder. Pediatric Grand Rounds, Henry Ford Hospital, January 21, 1999. Study Group: Clinical Research at the DMC-WSU SOM, "The Academic Mission of the Academic Health System: Creating Our Future", February 4-5, 1999. Advances in the diagnosis and treatment of pediatric conversion disorder. Pediatric Grand Rounds, Beaumont Hospital, Royal Oak, MI, February 10, 1999. Schizophrenia in the pediatric setting. Chairman’s Rounds, Beaumont Hospital, Royal Oak, MI, March 4, 1999. OCD in the school setting. Derby Middle School, Birmingham, MI, April 1, 1999. “Ready to Learn Summit” on neurodevelopment of childhood, Michigan State Legislature, June 10-11, 1999. Oakland County Task Force on Adolescent Suicide and Homicide, Pontiac, MI, June 23, 1999. Anxiety disorders in children. Department of Psychiatry & Behavioral Neurosciences Bi-Annual Meeting, Wayne State University, June 25, 1999. Child and adolescent research services. Department of Psychiatry & Behavioral Neurosciences Bi-annual Meeting, Wayne State University, June 25, 1999. Pediatric schizophrenia. Pediatric Grand Rounds, William Beaumont Hospital, Royal Oak, MI, June 29, 1999. Brain Imaging: Implications for substance abuse research. Harper Hospital, Detroit Medical Center, June 29, 1999. Assessment and treatment of childhood schizophrenia. Pediatric Grand Rounds, Beaumont Hospital, Royal Oak, MI, June 29, 1999. Wyeth Ayerst, “Treatment of adolescents with depression”, Michigan General and Child Psychiatrists, Plymouth, MI, June 30, 1999.

37

The role of brain imaging in the assessment and treatment of childhood onset neuropsychiatric disorders. Psychiatry Grand Rounds, University of Michigan, Ann Arbor, MI, July 20, 1999. Brain imaging: Implications for the assessment and treatment of adolescent psychiatric disorders. Adolescent Health Conferences, September 21, 1999. Symposium on new advances in the assessment and treatment of pediatric mood disorders. Course moderator and speaker. Children’s Hospital of Michigan, Detroit, MI. September 24, 1999. The importance of the dual uptake inhibitors in treating depression. Primary Care Physicians, Detroit, MI, September 30, 1999. Violence in children. Pediatric Grand Rounds, Beaumont Hospital, Royal Oak, MI, November 2, 1999. Obsessive compulsive disorder in kids. Grand Rounds, Huron Valley Sinai Hospital, Commerce Township, MI, November 10, 1999. Bridging the psychoanalytic-neuroscience interface. Michigan Psychoanalytic Institute, Livonia, MI, January 9, 2000 & March 5, 2000. Youth violence. Pediatrics Grand Rounds, Royal Oak Beaumont Hospital, Royal Oak, MI, December, 1999. Toward a neurodevelopmental model of OCD. Psychiatry Grand Rounds, University of Western Ontario, London, Ontario, Canada, March 9, 2000. New advances in pediatric bipolar disorder. Child Psychiatry Council, University of Western Ontario, London, Ontario, Canada, March 8, 2000. Pharmacogenetic imaging strategies: Implications for treatment development. 20th National Conference, Satellite Research Symposium Anxiety Disorders Association of America, March 23, 2000. New advances in the assessment and treatment of pediatric bipolar disorder. Grand Rapids Council of Child Psychiatrists, Grand Rapids, MI, April 13, 2000. Brain imaging: Implications for neurodiagnostic assessment and treatment development for childhood onset neuropsychiatric disorders. Michigan Council for Child and Adolescent Psychiatry, Novi, MI, April 18, 2000. Fulfilling lives for obsessive compulsive kids: New developments in pediatric OCD. OCD Foundation of Michigan, May 20, 2000. New advances in the assessment and treatment of Pediatric OCD. Moderated special symposium at Children’s Hospital of Michigan, WSU, and gave Pediatric Grand Rounds lecture, June 17, 2000. Pediatric Grand Rounds on clinical cases relevant to pediatric practice. 2 pediatric residents, Children’s Hospital of Michigan, WSU SOM and a 3rd year medical student, WSU SOM who rotated on my clinical service presented cases. I moderated, served as discussant and helped residents and students prepare their cases for presentation. July 7, 2000. New Advances in the assessment and treatment of pediatric eating disorders. Host, moderator and speaker, Pediatrics Grand Rounds and symposium, Children’s Hospital of Michigan, Detroit, MI, September 15, 2000.

38

Impact of alcohol on children in the home. Host and moderator for the Fischer-Cummings Visiting Professor on Substance Abuse. Pediatrics Grand Rounds, Children’s Hospital of Michigan, Detroit, MI, September 22, 2000. Developmental perspective on substance abuse: A neurodevelopmental approach to the conceptualization of obsessive and addictive behavior. The Detroit Bureau of Substance Abuse and Southeast Michigan Community Alliance, Cobo Hall, Detroit, MI, September 27, 2000. Skillman Center Conference for Children II, Pediatric Psychiatry and Psychopharmacology, Children’s Hospital of Michigan, Detroit, MI, October 10, 2000. Workshop, “Pharmacotherapy for Children”. Chairman, director and speaker. Detroit Wayne County Community Mental Health Agency (DWCCMHA) / Wayne State University Professional Development Series, November 9, 2000. Obsessive compulsive disorders as a fronto-striatal dysfunction. Mental and Behavioral Dysfunction in Movement Disorders: An International Symposium, Montreal, Quebec, Canada, October 11, 2001. Ask the Psychiatrist. Michigan Chapter of the National Alliance for the Mentally Ill, Grosse Pointe, MI, October 15, 2001. Moderated and hosted Fisher-Cummings Lectureship on Substance Abuse Disorders, Children’s Hospital of Michigan, January 8, 2002. New developments in pediatric OCD. Department of Community Health, Hawthorn Center, Northville, MI, January 22, 2002. Childhood and adolescent psychiatric disorders. Barnes School, Grosse Pointe Woods, MI, January 28, 2002. New advances in the assessment and treatment of childhood-onset neuropsychiatric disorders. Neurology Grand Rounds, Children’s Hospital of Michigan, March 15, 2002. New development in the treatment of pediatric depression. Chairman’s Rounds, Department of Pediatrics, Beaumont Hospital, Royal Oak, MI, July 16, 2002. Depression and anxiety. Pediatrics Grand Rounds, Children’s Hospital of Michigan, July 19, 2002. Moderated and hosted Fisher-Cummings Lectureship on Substance Abuse Disorders, Children’s Hospital of Michigan, January 2, 2003. Moderated and hosted Autism Symposium, Harper University Hospital and WSU SOM, March 21, 2003. Moderated and hosted Fisher-Cummings Lectureship on Substance Abuse Disorders, Children’s Hospital of Michigan, September 2, 2003. Moderated and hosted ADHD Symposium “New Advances in the assessment and treatment of ADHD across the lifespan”, Children’s Hospital of Michigan, September 13, 2003. Lecture on ADHD for Symposium, “Updates in Primary Care-Issues in Psychiatry for the Primary Care Practitioner”. McLaren Regional Medical Center, Flint, MI, March 13, 2004. Lecture rated on scale of 1 (Not useful) to 5 (Very useful). 46 attendees rated lecture. Coverage of the topic, 4.5; slides, handouts and AV materials, 4.3. Was objective met? 46 responded yes, 0 responded No. Lecture on "Developing Brain" at Schizophrenia (STEP) Symposium, John D. Dingell VA Medical Center, Wayne State University School of Medicine, Detroit, MI, May 21, 2004.

39

New advances in pediatric OCD. Chairman’s Rounds, Department of Pediatrics, Beaumont Hospital, Royal Oak, MI, March 30, 2004. Mechanisms of treatment response in pediatric obsessive compulsive disorder. Hawthorn Center Major Conference, October 5, 2004. The brain and major depressive disorder. KADIMA, Jewish Residential and Support Services for Adults with Mental Illnesses and the Department of Counseling and Psychological Services at Wayne State University, October 29, 2004. Psychotropic medication: Cardiac implications. Pediatric Cardiology Group, Department of Pediatrics, Children’s Hospital of Michigan, January 4, 2005. Assessment and treatment of dermatologic patients with psychiatric issues. Dermatology Grand Rounds, Department of Dermatology, Wayne State University School of Medicine, Detroit, MI, January 12, 2005. (Drs. Yousha Mirza and David Rosenberg; Dr. Rosenberg also helped in Dr. Mirza's preparation). Magnetic resonance imaging in obsessive-compulsive disorder: Past, present and future. Chairman’s Psychiatry Grand Rounds, Department of Psychiatry & Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI. January 26, 2005. (Dr. Rosenberg oversaw and helped with Dr. Mirza's preparation). What is the role of neuroimaging in the differentiation of childhood psychopathology? Child Psychiatry and Psychology Grand Rounds, Department of Psychiatry & Behavioral Neurosciences, Wayne State University School of Medicine and Children's Hospital of Michigan, Detroit, MI, February 8, 2005. (Dr. Rosenberg oversaw and helped with Dr. Mirza's preparation). Annual Pediatric Clinic Days Conference, Children’s Hospital of Michigan, May 6, 2005. Gave two lectures "New Advances in the Assessment and Treatment of Anxiety in the Pediatric Setting" and "Using Antidepressant/SSRI in Pediatric Depression and Anxiety" and participated in the entire day's clinic day. Learners included pediatricians, pediatric residents, fellows and staff, psychiatry residents and fellows, medical students and graduate students. No formal evaluations but received letter of commendation from co-chairs of Clinic Days Planning Committee, Dr. Mary Lu Angelilli and Ling-McGeorge, with comments including "Your lectures "New Advances in the Assessment and Treatment of Anxiety in the Pediatric Setting" and "Using Antidepressant/SSRI in Pediatric Depression and Anxiety" were expertly presented and well received by the audience"; "The question and answer sessions revealed the level of attention that the audience had around these two topics. "; "We appreciate that in a very short time frame you were able to present aspects of your research in these areas and practical treatment guidelines at the same time"; "Thank you again for your commitment and excellence in the delivery of the two lectures". Use of antidepressants in children. Clinic Day, Children's Hospital of Michigan, May 6, 2005. New developments in pediatric anxiety and depression. Clinic Day, Children's Hospital of Michigan, May 6, 2005. Image Retreat for MRI Imaging Center Wayne State University School of Medicine, June 1, 2005. Lecture on neuroimaging, “Cutting Edge Technologies” for Michigan Psych residencies (Wayne State, University of Michigan, Michigan State, Henry Ford), Novi, MI, June 17, 2005. New advances in pediatric obsessive compulsive disorder and depression. Child Psychiatry & Psychology Grand Rounds, Department of Psychiatry & Behavioral Neurosciences, Children’s Hospital of Michigan, Detroit, MI, September 13, 2005.

40

Department of Psychiatry & Behavioral Neuroscience Annual Alumni Educational Symposium, “Psychiatry: Progress and Promise”; Rosenberg DR and Keshavan MS, Course Directors. Detroit, MI, October 28, 2005. Insights into OCD. Department of Psychiatry & Behavioral Neurosciences Annual Alumni Educational Symposium, Detroit, MI, October 28, 2005. Evidence-based use of psychotropic medication in children and adolescents. Symposium, “Mental Health Issues in Children & Adolescents”. Macomb, Wayne, & Oakland Mental Health Authority; Troy, MI, November 4, 2005. fMRI in childhood. Magnetic Resonance Research Facility, Harper University Hospital, Detroit, MI, November 1, 2005. 14th Annual Francis P. Rhoades, M.D. Memorial Lecture, "Depression Across the Lifespan: Medical and Societal Costs", Wayne County Medical Society, Detroit Yacht Club, Belle Isle, MI, April 7, 2006. Associate Director and organizer for Institute of Mental Health Organizational Symposium with Introduction to Working Groups, McGregor Memorial Conference Center, Detroit, MI, September 8, 2006. New developments in OCD. Psychiatry Grand Rounds, Michigan State University, September 14, 2006. Bridging pediatrics and child psychiatry (with Dr. Herman Gray, President of Children’s Hospital of Michigan). Wayne County Community College, Detroit, MI, November 16, 2006. Chaired and moderated monthly (9) Child Psychiatry and Psychology Grand Rounds. “New developments in child psychiatry” to Children’s Hospital of Michigan Executive Committee. “New developments in pediatric mood and anxiety disorders” to Office of Development at the Children’s Hospital of Michigan, July 9, 2007. Effective intervention with children with OCD. Children’s Mental Health Issues Grand Rounds, Wayne County Community College, Detroit, MI, June 15, 2006. “Proposal to establish the Child Guidance Program” to Board of Trustees at Children’s Hospital of Michigan, November 7, 2007. Bipolar disorder in youth. Bright Nights: A Community-Based Forum at the Library, People’s Republic of Ann Arbor, November 13, 2007. Panel Discussion, “Bipolar Disorder in Children and Adults”. Bright Nights: A Community-Based Forum at the Library, People’s Republic of Ann Arbor, November 13, 2007. New advances in OCD. Child Psychiatry & Psychology Grand Rounds, Children’s Hospital of Michigan, March 11, 2008. Educational Program, "Pharmacotherapy of Obsessive Compulsive Disorder and Social Anxiety Disorder". Grand Rapids, MI, May 28, 2008. Lecture on bipolar disorder/depression to Laurencelle Foundation, Walled Lake, MI, May 29, 2008. Obsessive compulsive disorder and social pharmaceuticals. Lecture to local physicians, Troy, MI, July 22, 2008.

41

Obsessive compulsive disorder and social anxiety. Pine Rest Mental Health Services, Grand Rapids, MI, July 30, 2008. Obsessive compulsive disorder and social anxiety. Lecture to local physicians, Spring Lake, MI, July 30, 2008. Obsessive compulsive disorder and social anxiety. Lecture to psychiatrists serving primarily Medicaid patients, Dearborn, MI, November 14, 2008. New advances in childhood obsessive compulsive disorder. Birmingham Maple Clinic, Troy, MI, December 5, 2008. Chair & Moderator, Fisher Cummings Substance Abuse Symposium, Children’s Hospital of Michigan, Detroit, MI, May 1, 2009. New advances in pediatric OCD. Chairman’s Rounds, Department of Pediatrics, Beaumont Hospital, Royal Oak, MI, June 16, 2009. New advances in pediatric obsessive compulsive disorder. Psychiatry Grand Rounds, Department of Psychiatry, University of Michigan, Ann Arbor, MI, January 13, 2010. Integrating clinical programs in the school setting. Lecture to comprehensive school health coordinators of Macomb Intermediate School District, including teachers, nurses and social workers, January 15, 2010. New advances in pediatric obsessive compulsive disorder. Pediatric residents’ Psychiatry Lecture/ Morning Report, Children’s Hospital of Michigan, February 23, 2010. How studying the brain informs treatment: Studies in obsessive-compulsive disorder. Healthy Minds Across America 2010: Discovering Hope Through Sciences, Department of Psychiatry & Behavioral Neurosciences, Wayne State University, Detroit, MI, April 24, 2010. Metro Parent’s “Growing up in Today's Crazy World; Crushes, Frenemies, Gossip and Bullying”, hosted by Metro Parent and Children’s Hospital of Michigan. I helped organize and arrange for key talking points in two breakout sessions: “Crushes and Frenemies”, Georgia Michalopoulou, Ph.D. and “Gossip and Bullying”, Michael Butkus, Ph.D. November 30, 2010. Moderator and Chair, monthly Child Psychiatry and Psychology Grand Rounds, Children’s Hospital of Michigan. Moderator and Chair, monthly Child Psychiatry Case Conference, Children’s Hospital of Michigan. New advances in pediatric OCD. North East Guidance Center Wellness Academy Research Day, January 27, 2011. New advances in pediatric obsessive compulsive disorder. Pediatric Grand Rounds, Children’s Hospital of Michigan, Detroit, MI, January 28, 2011. Discussant, “Bipolar Disorder Early and Late Onset”, Chairman’s Grand Rounds, Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI, April 6, 2011. Moderated clinical speakers’ talks and question/answer period at Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI, May 6, 2011. Mechanisms of treatment response in pediatric OCD. Lecture to Psychiatry Department, University of Wisconsin, Madison, Wisconsin, August 26, 2011.

42

Invited Lecture symposium on brain imaging in child psychiatry at annual meeting of society of biological psychiatry 2012. Mechanisms of treatment response in pediatric OCD. Chairman’s Grand Rounds, Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI, June 13, 2012. “Neuropsychopharmacology and the emergence of psychiatrist as internists of the Minds”. Internal Medicine Grand Rounds, Detroit Medical Center, Detroit, MI, April 23, 2013. Hosted Fisher-Cummings Lectureship on Substance Abuse Disorders, Children’s Hospital of Michigan, October 10, 2014. Chaired and lectured at symposia on New Advances in Pediatric OCD at Society of Biological Psychiatry annual meeting, 2014 TEACHING Years at Wayne State University 1996-Present. Years at other colleges/universities:

University of Pittsburgh Medical Center, 1988-1996. Teaching at Wayne State University Undergraduate students Graduate students Selected

Physician Assistant student lecture series (lecture, handouts, case presentation and live patient interview.) 1997-2002

Graduate Clinical Neurosciences Course, 1997-Present

PYC 789, Graduate Clinical and Cellular Neurobiology Seminar 1997-Present.

PYC 7966-001, Independent Study, Research Credit Course for DPBN/CCN Graduate Students for 4-8 hours credit 1-2 students per year, 1997-Present

PYC 7150 Fundamentals of Neuroimaging, “Obsessive Compulsive Disorders”. 1.5 hours. 4 Masters level students per year. 1997-Present

PYC 7150 Fundamentals of Neuroimaging, “Child Psychiatric Disorders”. 1.5 hours. 4 Masters level students per year. 1997-Present

Child and Adolescent Psychopharmacology Course Director 1998-2007

2008-2009 Co-direct with Dr. Frank MacMaster Evidence Based Practicum for 2nd year Child Psychiatry Fellows, Wayne State University School of Medicine. Four 2nd year child psychiatry fellows.

.

2008 Director with Dr. Frank MacMaster (co-director), Brain Imaging Course for May 28, 2008, June 4, 2008, June 11, 2008 and June 18, 2008. 4 lecture series, 8 PGY-2 residents, Wayne State University.

43

2011: Director with Dr. Stanley and Dr. Diwadkar (co-directors). Brain Imaging Course for June 1, 2011, June 8, 2011, June 15, 2011 and June 22, 2011. 4 lecture series (2 by Dr. Rosenberg, 1 by Dr. Stanley, 1 by Dr. Diwadkar), 8 PGY-2 residents, Wayne State University.

2011 Lecture PYC 7140 Fundamentals of Neuroimaging, “Neuroimaging Studies in Affective Disorder”. 1.2 hours. 10 Masters and Ph.D. level students.

2011 Wayne State University President Academic Inauguration program, “New Approach in Child and Adolescent Psychiatry”.

2011 PYC 7150 Lecture on “Fundamentals of Neuropsychiatric Disorders”.

2012 Lecture PYC 7140 Fundamentals of Neuroimaging, “Neuroimaging Studies in Affective Disorder”. 1.2 hours. 11 Masters and Ph.D. level students.

2012 PYC 7150 Lecture, “Fundamentals of Neuropsychiatric Disorders: Child Psychiatric Disorder”.

2013 Lecture PYC 7140 Fundamentals of Neuroimaging, “Neuroimaging Studies in Affective Disorder”. 1.2 hours. 7 Masters and Ph.D. level students..

2013 Lecture on Pharmacoepidemiology of Psychotropic Medications in Youth. Year I CAP Pediatric Psychopharmacology, Tolan Park, 2 residents, Wayne State University.

2013 Lecture on Clinical Research Drug Trials in Pediatric Psychiatry for Year I CAP Pediatric Psychopharmacology, Tolan Park, 2 residents, Wayne State University.

2014 PYC 7150 Lecture, “Neuroimaging Studies in Affective Disorders”. 1.2 hours. 13 Ph.D. level students.

Medical students

Second year medical student Psychiatry Unit Lecture on Eating Disorders Series, 1996-Present (lecture, handout, case presentation, and live patient interview).

Child Psychiatry Elective, 3rd & 4th year medical students, 1997-Present.

Third year medical student Psychiatry Clerkship, Child and Adolescent Psychiatry, 1997-Present.

Third year medical student Clinical Neuroscience Elective, 1997-Present.

Lectures and Handouts on Clinical Psychiatry to third year medical students on consultation liaison service for 3rd year psychiatry clerkship, 1997-Present.

Fourth year medical student Elective, Child Psychiatry, 1997-Present.

Open House presentations and interactional workshops with WSU medical students interested in pursuing research opportunities, 1997-Present.

Ms. Kate Fitzgerald's Thesis Committee for Master of Science in Psychiatry and Neuroscience, 1998-1999. (Master’s obtained on 6/23/99).

Lecture to PSC 5600, College of Pharmacy and Allied Health Professions course on Recreational Drug use and abuse 1998-Present. Lecture on “PET” in psychiatry: Obsessive Compulsive Disorder to 4 Medical students. No written evaluations. Verbal feedback very favorable. Course director Randall Commissaries, Ph.D. sent letter saying “Your lecture was very well received by the students in the course.”

44

Objective Structured Clinical Examination of 3rd Year Medical Students (OSCE), WSU, 1998, 2000.

Thesis committee for Ms. Tiffany Farcione, WSU medical student completing master’s program in Department of Psychiatry & Behavioral Neurosciences. 2000-2001.

Lectures on Brain Imaging of Childhood Neuropsychiatry to 4th year medical students. July, October, November 2008 and February 2009.

Residents/Fellows

Lectures and handouts to pediatric psychology interns on pediatric psychopharmacology, Wayne State University & Children’s Hospital of Michigan, 1996-Present.

Lecture to and handouts PGY-II General Psychiatry Residents, Psychopharmacology II Series, Neurobiology of OCD, 1997-Present.

Course Director, Psychopharmacology Course for Child Psychiatry Fellows, WSU, 14 lectures per semester, 1998-Present (lectures, handouts, pretest and post-test examinations).

Pediatric Psychopharmacology series for General Psychiatry Residents, 1998-Present.

Clinical Psychopharmacology Case Conference for Child Psychiatry Fellows, WSU, (handouts and case presentation), 1997-Present.

Preparation of WSU psychiatry residents for Psychiatry Oral Board Examination, 1997-Present.

Behavioral Pediatrics rotation for pediatric residents, Children’s Hospital of Michigan, WSU. 1999-2000.

Child Psychiatry Elective for pediatric residents, Children’s Hospital of Michigan, WSU and Beaumont Hospital, 1999-2004.

Annual Pediatric Clinic Days, Children’s Hospital of Michigan, May 10, 2002.

Neuroimaging Applications in child/adolescent psychiatry presentation for Child Psychiatry Special Topics Seminar, Children’s Hospital of Michigan, March 17 & 24, 2004.

The Carman and Ann Adams Department of Pediatrics Wayne State University and Children's Hospital of Michigan, Faculty-Fellows Research Workshop on topic of Mechanisms of Treatment Response in Pediatric Mood and Anxiety Disorders. March 16, 2005

Structured Psychiatric Interviewing for Child Psychiatry Fellows Assessment Course, 4 Child Psychiatry Residents/Fellows.

Special Topics Seminar for Child Psychiatry Residents and Psychology Interns on Neuroimaging in Child Psychiatry and Psychology, 2 contact hours, 4 child psychiatry fellows, 4 child psychology interns, and 1 medical student.

Open Forum, 4 Second Year Child Psychiatry Fellows, WSUSOM, 1 hour, May 27, 2008.

Open Forum, 4 First Year Child Psychiatry Fellows, WSUSOM, 1 hour, July 16, 2008.

Open Forum, 4 pediatric psychology interns Children's Hospital of Michigan, 1 hour, July 23, 2008.

45

Child / Adolescent Psychiatry Pediatric Psychopharmacology Series: “Clinical Research Drug Trials in Pediatric Psychiatry.” October 18, 2011-Present.

Brain imaging in child psychiatry 2013-Present

Child / Adolescent Psychiatry Residency Pediatric "Pharmacoepidemiology of Psychotropic Medications in Youth”. 2014-Present Essays/Theses/Dissertations directed

Faculty Sponsor, Y. Kanawati, M.D., Child Psychiatry Fellow, WSU, working in my laboratory wrote up a research proposal/essay, “Brain Chemistry and Treatment Response in Bulimia”, and received an Eli Lilly Pilot Research Fellowship for $9,000 from the American Academy of Child and Adolescent Psychiatry.

Christine Post, M.D. and R. Khan, M.D., Child Psychiatry post-doctoral fellows working in pediatric anxiety research.

Faculty Sponsor, Frances Go, M.D. and Erin Malley, M.D., Child Psychiatry Fellows, University of Pittsburgh Medical Center who wrote with me, “Fluoxetine-induced Mania in Pediatric Obsessive Compulsive Disorder”. Journal of Child and Adolescent Psychopharmacology, 1998; 8:73-80.

Faculty Sponsor, Yvette Figueroa, M.D., Child Psychiatry Fellow, University of Pittsburgh Medical Center who first authored a paper with me, “Treatment of Pediatric Obsessive Compulsive Disorder with Clomipramine-SSRI Combinations”. Journal of Child and Adolescent Psychopharmacology, 1998; 8:61-67.

Faculty Sponsor, Frank MacMaster, He has first-authored 3 papers and also co-authored 4 papers. He presented his work at the Society for Neuroscience Annual meeting, presented his work at the Society of Biological Psychiatry meeting and the Michigan Neuroscience meeting. He also presented a paper at a national meeting on Developmental Neuroimaging that was subsequently published with Dr. Rosenberg in Progress in Neuropsychopharmacology and Biological Psychiatry. He first-authored a paper with Dr. Rosenberg on pituitary volume in pediatric obsessive compulsive disorder published in Biological Psychiatry. He also first-authored a paper on pituitary volume in pediatric major depression that has been accepted for publication by Biological Psychiatry. He is writing up an original research article for the Archives of General Psychiatry on familial vs. nonfamilial brain alterations in pediatric patients with major depression and a normative developmental paper on the pituitary for Brain Research. He has received the BRAINSTAR Award from the Institute of Neurosciences, Mental Health and Addiction (INMHA), a New Clinical Drug Evaluation Unite (NCDEU) New Investigator Award. He recently accepted an Endowed Chair in Pediatric Mental Health at Calgary University.

James Conway, Ph.D. Candidate, Neuropsychology, Windsor, Ontario. He did his dissertation on “Neuropsychological and Neuroimaging Correlates of Recent Onset, Medication Naive Pediatric Obsessive Compulsive Disorder: A Comparison to the Syndrome of Non-Verbal Learning Disabilities”, project with me at WSU. His project involves looking at the neuropsychological characteristics of treatment-naive pediatric obsessive compulsive disorder patients and monitoring cognitive changes after medication treatment. He is defended his dissertation in September 1999. Working with me from 1997-2000.

Faculty Sponsor, Vik Narula, B.S., graduate student, PYC 7020, Clinical Neuroscience, Wayne State University is doing an Independent Study with me looking at Brain Changes in the Temporal Lobe in Depressed Patients; “Temporal Lobe Structure and Pediatric Obsessive Compulsive Disorder”, 1998-2000. He was accepted to WSU Medical School August 1999 and graduated May 2003.

46

Faculty Sponsor, Vip Mangalick, BA graduate student PYC 7020: Clinical Neuroscience, WSU doing Independent Study looking at hippocampal and amygdala neuroanatomy in pediatric obsessive compulsive disorder, “Temporal Lobe Structures and Pediatric Obsessive Compulsive Disorder”, 1998-Present. Faculty Sponsor, Viviane Tawiles, B.A., PYC 7020 Graduate Student, Clinical Neuroscience, WSU, doing independent study with me looking at new treatments for childhood-onset obsessive compulsive disorder, 1998-1999. She was recently accepted into WSU program for Master’s in social work. Faculty Sponsor, Tiffany Farcione, first year medical student (now starting 2nd year), WSU, did summer research externship in my laboratory. She wrote up proposal with me to get this position, “Frontal Morphology and Pediatric Obsessive Compulsive Disorder”. She presented her work at the October American Academy of Child and Adolescent Psychiatry meeting in October, 1998, titled, “Frontal Morphology and Treatment Response in Pediatric Obsessive Compulsive Disorder.” She is doing special research fellowship and Master’s in Psychiatry Neurosciences in my laboratory. 7/1/00 – 6/30/01. Faculty Sponsor, Michael Swaney, first year medical student (now starting 2nd year), WSU, did summer research externship in my laboratory. He wrote up a proposal “Intra cranial volume in treatment response in Obsessive Compulsive Disorder”, with me to get this position. He presented his work at the October American Academy of Child and Adolescent Psychiatry meeting in October, 1998, titled, “Intracranial Volume and Treatment Response in Obsessive Compulsive Disorder.” Faculty Sponsor, Cheryl Bailey, 3rd year medical student, WSU. She received a James Comer Minority Research Fellowship working in my laboratory entitled “Brain Changes with Treatment Response in Pediatric Obsessive Compulsive Disorder”. She presented an abstract at the annual meeting of the American Academy of Child and Adolescent Psychiatry in October, 1998, entitled, “Basal Ganglia and Treatment Response in Pediatric Obsessive Compulsive Disorder.” Faculty sponsor for her presentation at the Medical Student Research Symposium, Wayne State University School of Medicine, Detroit, MI. She has received a full-time research training fellowship from the Program for Minority Research Training in Psychiatry funded by a National Research Service Award grant to the American Psychiatric Association from NIH. She also received a mini-fellowship from the program for minority research training in psychiatry to attend and present her work at the American Psychiatric Association and Society of Biological Psychiatry meeting, Washington, D.C., May 1999. Faculty Sponsor, Kate Fitzgerald, 4th year medical student, WSU. She is doing a 1 year research fellowship in my laboratory and pursuing a Master of Science of Psychiatry. She has first authored three papers; Fitzgerald K, MacMaster FP & Rosenberg DR: Neurobiology of Childhood OCD. In: Scahill L and King R eds, Child and Adolescent Clinics of North America, "Obsessive Compulsive Disorders in Children and Adolescents". W.B. Saunders Company, Philadelphia (1999); as well as a paper “Risperidone Augmentation of Serotonin Reuptake Inhibitor Treatment of Pediatric Obsessive Compulsive Disorder” (1999), Priority communication Biological Psychiatry (1999). She won 1st prize in the 1999 Medical Student Research Symposium and presented her work to the Society of Biological Psychiatry in May 1999. She also received a New Investigator Award from the New Clinical Drug Evaluation Unit, NIH, May, 1999. She received the AMA Award for excellence in clinical research, 4/99 and Psychiatry and Behavioral Sciences Award at the National Medical Student Research Symposium Galveston, Texas, April 1999. She recently received a Blue Cross Blue Shield Student Program Grant ($3,000) for the 1999-2000 Academic year. Applied for the 8th Annual Stanley M. Kaplan Medical Student Essay contest. Faculty Sponsor, Andrew Gilbert, 4th year medical student, WSU Faculty Sponsor; gave oral presentation of his original research paper on the thalamus at the Society of Biological Psychiatry Annual meeting, Washington, D.C., May 1999. Recipient of the 1999 American Academy of Child and Adolescent Psychiatry Robinson-Cunningham Award for best original research paper in child psychiatry. This paper was published in the May, 2000 AMA Archives of General Psychiatry. He recently received a Young Investigator Award from the International Congress of Schizophrenia Research. He was recently selected as a fellow by the American Psychiatric Institute for Research and Education/Janssen Scholars Program with me serving as his mentor over the next 2 years.

47

Faculty Sponsor, Lori Paulson, B.A. Presented her work at Society of Biological Psychiatry Annual meeting, Washington, D.C. May 1999. She has co-authored 3 papers currently under review. She is working on precise measurements of volumes of brain structures in patients with obsessive compulsive disorder, depression and eating disorders. Faculty Sponsor, Angela MacDonald, B.Sc., Presented her work at Society of Biological Psychiatry Annual meeting, Washington, D.C., May 1999. She has co-authored 3 papers currently under review. She is working on our behavioral and family therapy research projects in obsessive compulsive disorder. Faculty Sponsor, Kai Wicker, Integrated Premedical-Medical (Inteflex) Program, University of Michigan, May 17, 1999 – June 30, 1999. Faculty Sponsor, Amanda Cady, Integrated Premedical-medical (Inteflex) Program, University of Michigan, May 17, 1999 – June 30, 1999. Faculty Sponsor, April Sullivan, B.A. She presented an abstract at the Michigan Chapter of the Society for Neuroscience in May, 2000 and has also applied for the Research Associated Competition from the Michigan Chapter. She has coauthored 1 paper currently in press and another under review. 1999-2001. Faculty Sponor, Carla Nolan, B.A. She as coauthored 2 papers currently under review. 1999-2001. Faculty Sponsor, Shauna MacMillian, B.A., She has coauthored 2 papers currently under review. 1999-2003. Faculty Sponsor, Chris Bartoi, 4th year medical student, 1999. Faculty Sponsor, Dina Lim, 4th year medical student, 1999. Faculty Sponsor, Aditi Shrikhande, 4th year medical Student, 1999-2001. She presented her work at the annual Medical Student Research Symposium at WSU, 1/00 and at the annual meeting of the Society of Biological Psychiatry in Chicago, Ill and the Michigan Chapter of the Society for Neuroscience in May. 2000. She has also applied for the Graduate Student Competition at the Michigan Chapter of the Society for Neuroscience. Faculty Sponsor, Naveed Salem, 1st year medical student, WSU, 1999. Faculty Sponsor, Amy Bahl, Graduate Student, BMS, 1999. Faculty Sponsor, Dr. Shanthi Marur, post-doctoral MD Research Fellow. 1999. Faculty Sponsor, Renee Dwaihy, 4th year medical Student, WSU, 1999. Faculty Sponsor, David Grainger, 3rd year medical student, WSU, 1999. Faculty Sponsor, Peter Rigas, graduate student, Master of Sciences, WSU, 1999. Faculty Sponsor, Michael Hayes, 3rd year medical student, WSU, 1999. Faculty Sponsor, Howard Ditkoff, 4th year medical student, WSU, 1999. Faculty Sponsor, Mary O’Conner, 1999.

Faculty Sponsor, Marla Bartoi, Ph.D., post-doctoral fellow, 1999-2001.

Faculty Sponsor, Mary Jane Schaver, graduate student, BMS Program WSU, 2000.

48

Faculty Sponsor, Kenya Alexander, 2000. Faculty Sponsor, Akua Amponsah, has applied for the James Comer minority fellowship from the American Academy of Child and Adolescent Psychiatry, 2000. Faculty Sponsor, Lance Swick, CCN Ph.D. Student, WSU SOM, 2000. Faculty Sponsor, Rachel Madden, 2000. Faculty Sponsor, Nathan Foster, 2000. Faculty Sponsor, Gurdip Daffu, 2000. Faculty Sponsor, Christian Kriepke, CCN, Ph.D. Student, WSU SOM, 2000. Faculty Sponsor, Sharmalie Sarvanda, WSU SOM 4th year medical student 2000. Faculty Sponsor, Gia Walker, 4th year medical student WSU SOM, 2000. Faculty Sponsor, William Blacke, 4th year medical student WSU SOM. 2000. Faculty Sponsor, Meenakshi Chaku, BMS Graduate Student, WSU. 2001. Faculty Sponsor, Sherry Aujla, BMS, Graduate Student, WSU. 2001. Faculty Sponsor, Jonathan Perry, Medical Student, 2002-2005. Faculty Sponsor, Ethan Smith, Medical Student, 2002-2005. He first-authored original research article with Dr. Rosenberg published in Biological Psychiatry. He also was the first prize winner for the WSUSOM Medical Student Research Symposium. Faculty Sponsor, Maya Zayat, Medical Student, 2003. Faculty Sponsor, Sara Bobak, Medical Student, 2003-2005. Presented her work with Dr. Rosenberg at the annual meeting of the American Academy of Child and Adolescent Psychiatry in Washington, D.C. Faculty Sponsor, Darshan Pai, 2003 Faculty Sponsor, Dr. John Strauss, post-doctoral fellow 2004. Faculty Sponsor, Rachel Piszczor, 2005. Faculty Sponsor, Laura Strathdee, B.A., 2005. Faculty Sponsor, Ciprian Gradinaru, Undergraduate student, 2005-Present. Faculty Sponsor, Erin Bannon, 2006. Faculty Sponsor, Lyantta Howell, 2007. Faculty Sponsor, Courtney Hartlieb, 2007. Mentor, Tamara Vanderwal, M.D., PGY2, as part of integrated research training program of American Academy of Child and Adolescent Psychiatry, 2006.

49

Faculty Sponsor, Rachel Weisenfeld, 2008.

Faculty Sponsor, Emma Lister, 2008.

Faculty Sponsor, Eric Zimmerman, 2008.

Faculty Sponsor, Dayna LePlatte, 2008.

Faculty Sponsor, Dikla Eckstain, 2007-2008.

Faculty Sponsor, Joe Haddad, 2009.

Faculty Sponsor, Dr. Erin Falluca, 2008.

Ryan Silwanowicz, Alumni Research grant to do summer research project in our laboratory, 2009.

Faculty Sponsor, Geoffrey May, 2009.

Faculty Sponsor, Pallav Paveek, 2009.

Faculty Sponsor, Guarav Mishra, 2009.

Faculty Sponsor, Katie Cullen, 2009.

Faculty Sponsor, Kaleena Chilcote, 2010.

Faculty Sponsor, Alok Sachdeva, 2010.

Faculty Sponsor, Denise Dunlap, 2010.

Faculty Sponsor, Johnna Swartz, 2010.

Faculty Sponsor, Jillian Lee Wiggins, 2010.

Faculty Sponsor, Mary Joe Sidelko, Essay Advisor in Basic Medical Science, 2010.

Faculty Sponsor, Sunali Wadehra, 2010 – Present, 1st year WSU Medical Student Summer Fellowship through American Academy of Child and Adolescent Psychiatry.

Faculty Sponsor, Maya Holtrop, 2011.

Faculty Sponsor, Loan Lu, 2011.

Faculty Sponsor, Shakir Tehmina, co-mentor 2011

Faculty Sponsor, Malik Mossa-Basha, 2011

Faculty Sponsor, Joseph Schulte, 2011.

Faculty Sponsor, Daniel Barkmeier, 2011

Dissertation Committee Ph.D. Candidate Hilary Marusak 2012-2015.